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ABSTRACT 
Human T cell hybrids were produced following the polyethylene glycol-
mediated fusion of concanavalin-A-activated peripheral blood lymphocytes with 
a 6-thioguanine-resistant subline of the human T cell acute lymphocytic 
leukemia line CCRF-CEM. 
Four T cell hybrid lines were established by hypoxanthine-aminopterin-
thymidine selection and flow cytometric selection of the OKT3+ hybrids by 
sterile cell sorting on a FACS IV. Cell surface phenotype and the acquisition 
of functional hypoxanthine guanine phosphoribosyl transferase activity following 
hybridisation was used to confirm true human T cell hybrids were produced. 
Two assay systems, enabling the measurement of human in vitro antibody 
responses were developed and validated. Using one of these assays, a mitogen-
dependent system, it was demonstrated that hybrid line TT -4 constitutively 
produced an activity which suppressed pokeweed mitogen-induced antibody 
production. In addition, it was demonstrated that the TT -4-derived activity was 
capable of suppressing the proliferative response of normal lectin-activated T 
cells to exogenous sources of interleukin-2. 
Preliminary biochemicol studies of the hybrid-derived activity were undertaken. 
Sephacryl S-200 chromatography produced three major peaks of suppressor activity 
(>250, 120-140, 60-80 Kdal). The activity was partially acid and alkali labile, 
dithiothreitol sensitive, affected by the monosaccharides a-methyl mannoside, 
L-fucose and N-acetyl glucosamine but not by L-rhamnose. 
These studies confirm that somatic cell hybddisation techniques can be 
successfully applied for the production of human regulatory Iymphokines. 
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BACKGROUND 
The work presented in this thesis forms part of a larger study being 
undertaken in the Department of Medicine, Christchurch Clinical School 
of Medicine investigating human immune response regulation. Studies 
undertaken in this laboratory have centered on the regulation of human 
cytotoxic T lymphocyte activation by suppressor lymphocytes and by a 
mixed lymphocyte culture-derived suppressor factor (Crosier & Broom 1981a,b). 
During the course of these studies it became apparent that alternative, 
stable sources of suppressor lymphokines would be necessary before detailed 
studies of the biochemical nature of these lymphokines could be undertaken. 
My brief was composed of two parts: 
1) to develop somatic cell hybrids as alternative sources of 
human suppressor lymphokines, and 
2) to determine if these suppressor lymphokines affected 
other types of human immune responses. 
It was decided to investigate the role, if any, of hybrid-derived lymphokines 
in the regulation of human antibody responses. This necessitated the develop-
ment of assay systems capable of measuring human in vitro antibody responses. 
I. 
CHAPTER 1. 
LITERA TURE REVIEW 
1.1 GENERAL INTRODUCTION 
liThe immune system is an infinitely complex and finely tuned network of 
cells, receptors and molecules which interact with one another in a genetically 
controlled manner that is manifested ultimately in the process known as 
differentiation ll (Katz, 1977). 
The essential function of an immune system is defence against pathogens 
and tumors. Lower animals possess innate (non specific) immune mechanisms, 
for example- phagocytosis of bacteria by specialised cells. In addition higher 
animals have evolved an adaptive or acquired immune response. This type of 
immune response is flexible, specific and provides a more effective protection 
against infection. Adaptive immune responses display three important 
characteristics; memory, specificity and the ability to recognise "non-self". 
Initial contact with antigen imparts some memory which allows a rapid 
secondary response if the same antigen is encountered at some later stage. 
The establishment of memory or immunity by one antigen does not confer 
protection against another unrelated antigen, hence the specificity of immune 
responses. The ability to recognise one antigen and to distinguish it from 
another goes further to enable the recognition of "foreigness" and the 
discrimination of "self" antigens from "non self" antigens. A failure of this 
important discrimination can lead to autoimmune disease. 
On theoretical grounds, what would be the most efficient way to 
organise an immune system which could adequately protect an animal from 
infection and display the ideal characteristics of memory, specificity and the 
recognition of "non self" ? 
The endocrine and nervous systems have evolved in such a way that all 
the specialised organs and tissues can work in a fully integrated manner. 
Integration is achieved by two systems; firstly by means of electrical 
impulses and secondly by chemical substances, or hormones, which are 
produced in certain tissues and glands and are distributed throughout the body 
by means of the circulatory system. Hormones therefore produce their effects 
by influencing the activities of their target organs, which in most cases are 
spatially separated from the cells producing them. Hormones are therefore 
the chemical messengers which integrate the endocrine system. The immune 
system has a number of parallels to the endocrine and nervous systems. To 
enable a fully integrated response to foreign lIantigens ll, the immune system is 
organised as sets of clones of cells and each clone expresses on its surface 
receptors for a particular antigenic structure. A foreign antigen, if it crosses 
the external barriers of the body, under normal circumstances will be 
recognised by a particular antigen-reactive clone of cells. Specific antigens 
therefore select a responding clone and cause its activation. This clone of 
antigen-reactive cells can then act to eliminate the threat via its effector 
mechanisms. In a manner analagous to the endocrine system, the immune 
system can integrate this cellular response to antigen by secreting molecules 
(llimmunological hormones") which can either recruit other immunocompetent 
cells or can amplify the response by expanding the numbers of antigen-
reactive cells. Organising an immune system in such a way that utilises 
specific antigen-reactive cells and "immunological hormones" enables a faster, 
more integrated response to antigen than would be possible with a generalised 
mechanism of recirculating cells of multiple specificity and reactivity. This 
form of regulation also enables the down-regulation of immune responses when 
the invading antigen is no longer a threat. 
1.2 ORGANISATION OF THE IMMUNE SYSTEM 
2. 
Tissue culture techniques have permitted the closer investigation of this 
concept of integration of immune responses by selected populations of cells 
under conditions which can be controlled to a greater extent than is possible in 
intact animals. Murine and human studies have established that an effective 
immune response involves complex interactions between effector and regulatory 
cells of the haematolymphoid system. 
To understand these interactions one must first consider, in general terms, 
the organisation of the immune system. Lymphoid cells of the haematolymphoid 
system are divided into two major classes, T lymphocytes (T cells) and 
8 lymphocytes (8 cells). Immune molecules associated with, or secreted by these 
two classes of cells, have two important roles in immune responses. One is 
protective and the other regulatory. This protective role requires two classes of 
effector molecules to deal with the major classes of infectious disease. The 
..... 
regulatory functions of the immune cells determines self-nonself discrimination 
as well as the magnitude of the responses. 
Humoral antibody (an effector molecule) is immunoglobulin secreted by 
octivated B cells and has a major protective role in the defence against extra-
cellular pathogens e.g. bacteria, fungi, protozoa. Cell mediated effector 
molecules are non-immunoglobulin in nature and act as antigen receptors on 
thymus-derived effector T cells. Effector T cells are concerned with 
combatting intracellular pathogens e.g. viruses, tumorigenic cells, rickettsia. 
Humoral antibody plays a regulatory role via antigen-specific feedback and can 
either enhance or inhibit responsiveness. There is a fundamental assymetry in 
the immune system i.e. T cells are reqUired for the induction of B cells and not 
vice versa. Regulatory T cells are seen as the controllers of immune 
responsiveness. The function of T cells as regulators or effectors results from 
their interaction in mediating precisely controlled cell-cell signalling interactions. 
Different T cell subpopulations constitute the effectors or regulators e.g. 
delayed type hypersensitivity T cells can mediate effector functions in vivo. 
Cytotoxic T cells also act as effectors by lysing virally infected target cells. 
In contrast, regulatory T cells can act to augment (T helper cells, Th) or 
suppress (T suppressor cells, Ts) immune responses. The first important 
concept of the immune system therefore is the organisation of lymphocytes as 
sets of clones of effector and regulatory cells. 
The second concept is that an immune response (and its regulation) 
results from the interaction of these clones of cells. T cells are known to 
interact with B cells and macrophages as well as other T cells (Katz, 1977). 
These interactions result in the modification of the immune response. As 
stated above this modification may be either positive (help), negative 
(suppression), or more likely some combination of both. This overall effect is 
referred to as immunoregulation. Every type of immune response has now 
been shown to be affected by immunoregulation. These include antibody 
production (Rowley & Fitch,1964), changes in immunoglobulin isotype expression 
(Kishimoto et aI, 1978), changes in antibody specificity and binding avidity 
(Gershon & Paul, 1971), termination of antibody responses (Taylor & Bastan, 
1976), T and B cell proliferation (Rich & Rich, 1974), activation of cytotoxic 
T cells (Altman et aI, 1979), and even the regulatory mechanisms themselves 
(Durum et aI, 1980). 
The concept of cellular interaction in immunoregulation was first 
demonstrated in the studies by Claman et 01 (1966), Davies et 01 (1967) and 
Miller & Mitchell (1968). These groups established that Th cells interact with 
B cells in the development of antibody responses. These observations lead to 
the third important feature of the immune system, the idea that soluble 
4. 
factors secreted by lymphocytes mediate these interactions by acting as 
communication signals between the cells producing them and other cells 
carrying the relevant acceptor/receptor sites for the factors. The first report 
by Dutton et 01 (1971), that a mediator present in the supernatant of allogeneic 
mixed leukocyte cultures: could augment antibody responses against sheep red 
blood cells in vitro paved the way for the identification of numerous other 
immunoregulatory factors. 
These studies have shown that soluble mediators produced predominantly 
by activated T cells can have profound regulatory effects on the immune 
system, as well as other systems of the multicellular organism. 
This network of immunoregulatory factors is exceedingly complex when 
one considers that numerous soluble factors (lymphokines) can be generated by 
stimulating T cells with specific heterologous antigens, alloantigens or mitogens. 
These lymphokines can suppress or help immune responses, are antigen-specific 
or nonspecific, bear or lack antigenic determinants encoded by the major histo-
compatibility complex and are either major histocompatibility-restricted or 
unrestr icted in their action on target cells. 
1.3 CONVENTIONAL L YMPHOKINE SOURCES 
1.3.1 Limitations of conventional lymphokine sources 
Even though a large number of publications have described T cell-
derived lymphokines and their effects on biological responses, there are still 
major difficulties in determining the structure-function relationships and 
biological significance of these lymphokines. These difficulties result from the 
shortcomings of conventionally derived lymphokine preparations; 
(1) the heterogeneous producer cell population and 
(2) the limited amounts available for detailed biochemical analysis. 
T cell subpopulations or clones can be distinguished by function or on the 
basis of cell surface receptor expression. Highly purified T cell subpopulations 
have become possible through the use of monoclonal antibodies to cell surface 
receptors (Reinherz et aI, 1979), but since macrophages (or other types of antigen 
processing cells) and their secreted products are necessary for T cell activation 
in conventional cultures, it is difficult to exclude the contribution of non-T cells 
ta the activities detected in the culture. It is likely therefore that conventional 
lymphokine preparations will contain factors produced by different T cell 
subpopulations as well as those arising from non-T cells. Workers have reported 
culture supernatants containing mixtures of a) antigen-specific or non-specific 
helper and suppressor factors (Kilburn et aI, 1979; T okuhisa et aI, 1978; 
Kishimoto & Ishizaka, 1974) or b) antigen-specific suppressor factors produced by 
at least two different Ts subpopulations (Hirai & Nisonoff, 1980). This hetero-
geneity could lead to incorrect interpretation of the biological role of the factors, 
if for example, a suppressor factor is masking the effect of a helper factor. 
Normal lymphocytes have a finite and usually short lifetime in culture, 
therefore it is in general difficult to obtain uniform and homogeneous lymphokine 
preparotions in large enough quantities to allow detailed biochemical purificotions 
and structural studies to be undertaken. As the biological assays available to 
identify these lymphokines have expanded so have the numbers of lymphokine 
activities reported increased. This had led to confusion in some cases in deciding 
whether two distinct biological activites are mediated by the same or by 
different molecules (Watson et aI, 1979; Farrar et ai, 1980a; Aarden et aI, 1979). 
1.3.2 New approaches 
Lymphokine biologists in the last five years have attempted to over-
come these problems by establishing stable and homogeneous T cell lines 
secreting distinct lymphokines. For these two important criteria to be met, the 
lymphokine-producing T cell line should be monoclonal, or at least highly enriched, 
and have a long lifespan in culture. Enrichment of the desired T cell subpopulation 
is now possible. Monoclonal antibody staining and positive selection utiliSing 
fluorescence activated cell sorting, negative cell depletions using monoclonal anti-
body and complement-mediated lysis or conventional limiting dilution cloning are 
now widely used. Techniques allowing the immortalisation of the derived T cell 
lines have also been refined in recent years (Fathman & Fitch, 1982). 
1.4 AL TERNA TIVE L YMPHOKINE SOURCES 
1.4.1 Introduction 
Techniques allowing the immortalisation of lymphokine producing cell 
6. 
lines have been developed far normal as well as neaplastic T cells. Neoplastic 
T cells have been selected for constitutive or induced lymphokine secretian or 
they have been fused with lymphokine-secreting normal T cells using somatic 
cell hybridisation techniques. Normal T cells can now be maintained in culture 
by the addition of "growth factors" to the culture medium, or in some instances 
in the addition to "growth factors", by repeated stimulation of the cells with 
antigen. These three techniques all have advantages over the conventional 
production of lymphokine-containing "conditioned-medium" which involves 
stimulating a mixed population of cells with antigen or mitogen to produce a 
diverse population of lymphokines (see Sections 1.4.2 - 1.4.4). 
1.4.2 Neoplastic T cell lines 
During the last ten years investigators have attempted to develop 
model systems which fulfill the requirements of clonality and immortality by 
lymphokine-secreting lymphocytes. The basic assumption that tumors are 
derived from a single transformed cell have prompted workers to try adapting 
human and murine T cell leukemias and lymphomas to long-term growth in 
culture (Minowada et aI, 1972). This inherent clonality probably represents 
normal lymphocytes which have been "locked" in a certain stage of differentiation 
and which are unable to proceed further along their differentiation pathway. 
Plasmacytomas (neoplastic mature immunoglobulin-secreting B cells) 
have been useful in the study of antibody diversity and the B cell receptor for 
antigen. B cell tumors as well as secreting homogeneous immunoglobulin 
molecules have also been shown in some cases to retain other functions 
characteristic of normal B cells such as responsiveness to activation and regulat-
ory signals (Moller, 1977). 
Even though a number of human and murine T cell leukemias and lymphomas 
can now been successfully grown in culture (Gillis & Watson, 1980a; Ruscetti & 
Gallo, 1981; Farrar et ai, 1980b; Gillis et ai, 1980b), few definitive methods 
for reproducibly culturing neoplastic T cells are available. Little is known 
regarding the capacity of these lines to perform particular immunological 
functions. 
Few neoplastic T cells have been described which exhibit antigen-specific 
functions. Glade & Hirschorn (1970) though, reported that a number of human 
lymphoid cell lines could secrete various antigen-nonspecific lymphokines. 
As new techniques have become available to define more precisely both 
the cell surface phenotype and functional characteristics of murine and human 
neoplastic T cell lines, so have a number of antigen-nonspecific lymphokine 
activities been identified. In some instances these lymphokines have been 
characterised (discussed later). 
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Antigen-specific neoplastic T cell clones have been developed in mice 
(Finn et aI, 1979) by priming T cells with keyhole limpet hemocyanin and 
infecting these in vitro with radiation leukemia virus. These infected cells 
were propogated by injecting them into the thymus of syngeneic recipients. 
Some antigen-specific cells derived in this way were shown to serve as carrier-
specific Th cells in both in vivo and in vitro responses to dinitrophenyl-KLH 
conjugates (DNP-KLH). Later studies confirmed that these techniques could be 
used to create neoplastic murine T cell lines which secrete antigen-specific 
factors (Eshhar, 1982). 
Similar approaches using human T cells primed and transformed in vitro 
have not been reported. Human B cell transformations using Epstein-Barr Virus 
have been widely used to generate lymphoblastoid cell lines (Baumal et ai, 1971). 
Additional human neoplastic T cell lines will undoubtedly be established in the 
future as the techniques enabling functional and phenotypic studies of neoplastic 
T cells are now widely used. 
1.4.3 Normal T cell lines 
Studies by MacDonald et al (1974), demonstrated that antigen-
specific T cells could be grown in culture for extended periods if they were 
periodically restimulated with alloantigen. In general though, these lines 
eventually stopped growing and ceased secreting biological factors. 
In 1976, Morgan et 01 reported that conditioned-medium derived from 
phytohemagglutinin (PHA)-stimulated human lymphocytes could support the 
growth of other activated human lymphocytes. Surface phenotype and functional 
studies demonstrated that the proliferating cells were in fact normal T cells 
(Ruscetti et ai, 1977). Gillis and Smith (1977) named the factor responsible for 
this proliferation, T cell growth factor (TCGF). TCGF was later renamed 
interleukin 2 (IL-2), to ease the difficulties relating to a number of lymphokines 
described by different groups on the basis of function, but which probably 
represented the same molecular entity (Aarden et aI, 1979). The terms TCGF 
and IL-2 are used interchangeably, but strictly, crude TCGF refers to a 
soluble lymphokine defined by its ability to support the long-term growth of 
mitogen or antigen-activated lymphocytes. Both murine and human IL-2 have 
been biochemically characterised (Watson et aI, 1979; Gillis et aI, 1980c). 
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A cDNA coding for human IL-2 has also been cloned. The DNA sequence 
corresponding to the putative human IL-2 gene has also been determined 
(Taniguchi et aI, 1983). IL-2, in some cases in association with repeated 
antigen stimulation, has enabled the establishment of T cell lines with cytotoxic 
functions (Gillis & Smith, 1977; Baker et ai, 1979). Improvements in t.echnology 
have assisted the progression from T cell lines to T cell clones to the extent 
that antigen-reactive clones specific for alloantigens, particulate antigens and 
now soluble protein antigens have been reported (reviewed in Fathman & Fitch, 
1982). It has not been established though to what extent these IIL-2-addicted" 
T cells truly represent normal T cells. Chromosomal aberrations have been 
found in certain IL-2-dependent murine cytotoxic T cell lines, but these do not 
appear to be malignant in vivo (Nabholz et ai, 1980). 
A ttempts to create monoclonal T cell lines usually rei y on the repeated 
stimulation in vitro with antigen plus antigen presenting cells in the presence of 
IL-2 (Apte et aI, 1981). These approaches create several potential problems, 
for example a biased selection of a T cell subpopulation which grows well in 
culture, selective stimulation of T cells responsi-ve to IL-2 but not antigen-
specific, and the selection of a T cell subpopulation with abnormal specificities 
for antigen. 
1.4.4 Somatic cell hybrids 
A third approach to the problem of developing stable sources of 
regulatory lymphokines has taken advantage of the techniques of somatic cell 
hybridisation as refined by Kohler & Milstein (l975) for the production of B cell 
hybridomas secreting antibodies of defined specificity. This monoclonal antibody 
(McAb) technology has revolutionised modern immunology (reviewed by Katz, 
1982). T cell 'somatic cell hybridisation allows the fusion of a single lymphokine-
secreting normal or activated T cell to a selected neoplastic T cell. The result-
ing hybrid is immortalised due to the property of the neoplastic cell to grow 
indefinitely, thereby preserving the secretory function of the normal lymphocyte. 
This approach was initially applied to murine T cells (Hammerling, 1977; Goldsby 
et aI, 1977; Kohler et aI, 1977) and was adapted by Grillot-Courvalin et 01 (1981) 
to enable the isolation of human T cell hybridomas with specific T cell functions. 
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This first described human hybridoma was prepared from the fusion of a 
bromodeoxyuridine-resistant (thymidine kinase negative) derivative of the human 
T cell acute lymphocytic leukemia (T -ALL) line KE37 with peripheral blood T cells 
from a patient with agammaglobulinemia. One of the hybrid lines isolated 
constitutively secreted a factor which suppressed B cell differentiation induced by 
pokeweed mitogen (PWM). 
The biochemical rationale enabling the construction of human T cell 
hybridomas will be discussed in Section 1.8.2. A number of functional human 
T cell hybridomas constructed by other workers will be discussed in Section 1.8. 
1.5 SELECTION OF T CELLS FOR IMMORT ALISA TION 
Selecting and enriching the desired activated T cells is vital, especially in 
the case of lines expressing antigen-specific functions. The proportion of cells 
specific for antigen, following primary antigenic stimulation, is often very low, 
therefore it is desirable to enrich the antigen-specific population before they 
are immortalised. 
Antigen-specific human Th or cytotoxic T cells are usually enriched by 
repeated stimulation in vitro (Bach et ai, 1979). This treatment eliminates most 
of the irrelevant T cells and highly enriches for antigen-specific cells. 
Selective activation and enrichment of Ts cells has been possible with high 
doses of soluble antigens or high doses of T cell specific mitogens (Rich & 
Pierce, 1973; Uytdehaag et aI, 1979; Taniguchi & Miller, 1978; Peavy & 
Pierce, 1974). 
The advent of monoclonal antibodies and fluorescence activated cell sorting 
has enabled the selection of T cell subpopulations depending on their specific 
membrane phenotype expression (Reinherz et ai, 1979). 
1.6 BIOLOGICAL ASSAYS FOR L YMPHOKINE ACTIVITY 
Assuming one is able to generate stable, homogeneous and immortal cell 
lines the next step is screening the derived lines for constitutive or inducible 
lymphokine activity. As only a very limited number of lymphokines have been 
purified to homogeneity, the assays for these Iymphokines are still primarily 
biological in nature. For this reason it is often difficult to determine if two 
distinct lymphokines possess the same biological activity or whether one 
lymphokine species may mediate different biological effects. 
10. 
Most of the assays currently available have two major limitations. Firstly, 
since most preparations have more than one activity present, it is difficult to 
ascribe a particular activity to a given lymphokine. Secondly, the target cells 
used to assay lymphokine activities are often heterogeneous in nature. 
Cloned cell lines with an absolute requirement for a particular lymphokine, 
such as the IL-2-dependent CTLL-2 line (Gillis & Smith, 1977), will help to over-
come these difficulties in assigning biological activity to a particular molecule. 
In the case mentioned above, IL-2 activity is measured by its ability to promote 
the growth of this IL-2-dependent cytotoxic T cell line. By using a cloned T cell 
line, it is clear that IL-2 acts directly on a T cell. Similarly the interleukin-1 
(IL-l) bioassay developed by Gillis & Mizel (1981) relies on a cloned line, in 
this instance derived from a murine T cell lymphoma. This cloned line responds 
to Concanavalin A (ConA)-stimulation by producing IL-2, but only when it is 
costimulated with the macrophage-derived lymphokine IL-1. This therefore 
provides a definitive assay for IL-l activity. 
The development of antibodies, in particular McAbs, to specific factors 
will greatly advance lymphokine biology by assisting the development of binding 
assays for lymphokines. 
Somatic cell hybridisation techniques have enabled the production of McAbs 
recognising human IL-2 (Gillis & Henney, 1981) and alpha interferon (IFN-a) 
(Secher & Burke, 1980). 
Lymphokine research in the future should allow the closer investigation of 
the mechanism of action and physiological role of ly'mphokines. The techniques 
being developed include; cloned lymphokine-secreting T cell lines, anti-Iymphokine 
McAbs and cloned populations of target cells for use in bioassays. 
Even though clonal assays are being developed to measure lymphokine 
activity, less specific assays reported over the last 10 years have still enabled 
the identification of various lymphokines. 
The first assays for regulatory lymphokines generally measured their effects 
on antibody responses in vitro, specifically their ability to augment unfraction-
ated spleen cell antibody production, or Th-replacing factor activities in 
cultures of T cell-depleted spleen cells (Rubin & Coons, 1972). Later, other 
assays measuring the polyclonal activating properties of lymphokines were 
developed. This was assessed by the proliferation of responding B cells or total 
Ig secretion (Geha et aI, 1977). Other bioassays were developed to measure the 
effects of T cell-derived lymphokines on macrophages, for example the T cell 
derived lymphokine responsible for the activation of macrophages, macrophage 
activating factor (Nathan et 01, 1980). Other T cell derived mediators, which 
act on target cells not directly involved in the immune response have been 
assayed in nonimmunological systems. These include: 
1) factors which promote the differentiation of hematopoietic 
progenitor cells i.e. colony stimulating factor, 
2) mast cell growth factor, which mediates mast cell growth in 
culture and, 
3) gamma interferon, which was originally assayed by its antiviral 
activity, but which is known to have potent immunoregulatory 
activity. 
1.7 REGULATORY L YMPHOKINES IDENTIFIED TO DATE 
In the last ten years a large number of biologically active mediators have 
been described. Athough relatively few studies of human T cell-derived immuno-
regulatory factors have been performed it is now clear that many of the findings 
and rules established in murine studies apply equally well to human lymphokines. 
Regulatory lymphokines have been derived from normal or neoplastic T cells, or 
more recently from T cell hybridomas. 
It is convenient to classify T cell-derived immunoregulatory factors into 
those which are either antigen-specific or antigen-nonspecific in their action. 
Antigen-specific factors regulate immune responses exclusively to the antigen 
which induced their formation. These factors bind the respective antigen and 
bear determinants encoded by the MHC. These factors have been reviewed by 
Tada & Okumura, (1979) and Altman & Katz, (1980). 
In contrast, antigen-nonspecific factors act in a polyclonal manner, and 
many, although not all, do not bear detectable MHC encoded products. 
1.7.1 Antigen-specific lymphokines 
Depending on biological activity, antigen-specific lymphokines are 
divided into two major groups i.e. helper factors (ThF) or suppressor factors 
(TsF) •. ThF act to replace Th cells and provide help to antigen-primed effector 
cell precursors, whether T or B cells whereas TsF act to inhibit or suppress the 
immune response. 
1.7.1 (a) Antigen-specific helper factors 
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Table 1.1 describes a number of recently identified antigen-
specific factors displaying helper activity. In the main, the derivation of T cell 
lines secreting antigen-specific immunoregulatory factors has involved in vitro 
or in vivo immunisation of the T cells with the relevant antigen. An extensive 
review of previously described monoclonal, antigen-specific helper factors has 
been presented by Altman & Katz (1982). 
1.7.1 (b) Antigen-specific suppressor' factors 
Suppressor factors are soluble inhibitors of the immune response 
which have been shown to actively participate in the regulation of the immune 
system. Four major classes of antigen-specific T cell suppressor factors have 
been descr ibed. These are: 
1) carrier-specific suppressor factors, 
2) polypeptide-specific factors, 
3) factors which cause tolerance and supression of delayed type 
hypersensitivity and, 
4) factors which contribute to the failure of host immune 
responses to reject certain tumors. 
Table 1.2 describes a number of selected antigen-specific suppressor factors 
which have been reported. There have been a number of contradictory reports 
concerning the expression of MHC and V H determinants, MHC restriction, 
antigen versus idiotype specificity and the target cells for antigen-specific factors. 
Krakauer & Clough (1981) have published an extensive review of suppressor cells 
and their factors and discuss many of these questions. 
The availability of monoclonal sources of antigen-specific lymphokines 
will allow the closer investigation of a number of immune mechanisms, for 
example: 1) using monoclonal TsF or ThF and cloned target cell populations 
Antigen 
Human Influenza virus 
strain A/3Xl 
(T ,G)-A-L 
(T ,G)-A-L, GAT 
Tetanus toxoid 
Ovalbumin 
Murine KLH, ovalbumin 
or human IgG 
TABLE 1.1 
ANTIGEN - SPECIFIC HELPER FACTORS 
Derivation 
7d in vitro priming, 
TCGF medium 
In vitro priming, (T,G)-
A-L primed m¢ & TCGF 
4 d in vitro priming 
T cell hybridoma : Jurkat 
6TG-3 X TeT-specific 
Th line 
120 hr in vitro priming 
T cell hybridoma : Antigen 
primed T cells X tumor 
lines 
Assay system 
2° Ab response to virus 
ThF activity in murine spleen 
cell Ab production 
IgM response to hapten-
carrier conjugates 
IL-2 production after antigenic 
stimulation in presence auto-
gous irradiated m¢ 
Initiation of T-dependent IgM 
response 
IL-2 production following 
antigen stimulation, anti-
TNP plaque response 
Comments 
Factor genetic restriction 
associated with HLA-DR 
Factor binds antisera to 
HLA-DR & ~ determinants 
Response segregates with HLA 
complex 
Hybridoma retains helper 
activity of parent 
Acts in early stages antigen-
induced B cell activation & 
later stages B cell differentiation 
Stimulatory B cell signals 
independent of Ig receptors 
by T cell recognition of antigen 
and/or I region 
References 
I 
2 
3 
4 
5 
6 
c..J 
. 
Ab 
ThF 
rr¢ 
(T ,G)-A-L 
antibody 
T helper factor 
macrophage 
References: 
1. 
2. 
3. 
Fisher et aI, 1981 
Apte et aI, 1981 
Woody et aI, 1979 
4. DeFreitas et aI, 1982 
T cell hybridoma: adopt~ 
ively primed (T,G)-A-L 
specific thymocytes X 
BW 5147 thymoma line 
Spleen cell Ab production Binds heterologous rabbit 
antisera to VH region of 
murine Ig 
(T ,G)-A-L 
GAT 
Tyrosine, glutamic acid, alanine, lysine polymer 
glutamic acid, alanine, tyrosine polymer 
KLH 
5. 
6. 
7. 
Keyhole limpet hemocyanin 
Heijnen et aI, 1981 
Roehm et aI, 1982 
Essher et aI, 1980 
7 
t 
TABLE 1.2 
ANTIGEN - SPECIFIC SUPPRESSOR FACTORS 
Antigen 
Human ovalbumin 
Murine KLH 
SRBC 
Sheep erythro-
Derivation 
120 hr in vitro priming with 
high doses ovalbumin 
T cell hybridoma : in vivo 
primed & enriched Ts cells 
x BW 5147 line 
T cell hybridoma 5d SRBC 
primed murine spleen cells 
x BW 5147 line 
Ta clone SRBC primed 
cyte glycophorin spleen cells 
GAT T cell hybridoma : GAT 
primed Ts cells x BW 5147 
line 
Assay system 
Suppression Antigen-induced 
prc formation 
Suppression anti-DNP IgM 
& IgG spleen cell response 
Suppression IgM response 
to SRBC 
Inhibition anti-SRBC 
helper-function 
Suppression GAT-MBSA 
response 
Comments 
Effector Ts product, acts 
on Th cells in antigen-
induced PFC response 
Antigen binding & I-J coded 
molecules on TsF indep. synth-
esised in cytoplasm, secreted 
in active associated form 
85 & 25 Kdal peptides, 200 Kdal 
native molecule. Heavy chain 
binds SRBC 
70 Kdal suppressor glycoprotein, 
45 & 24 Kdal subunits 
24 Kdal hydrophobic 
glycoprotein 
References 
1 
2 
3,4 
5 
6 
SRBC 
Ts 
sheep red blood cell 
T suppressor cells 
Th : T helper cells PFC plaque forming cells MBSA methyl bovine serum albumin 
Tsr: T suppressor factor 
References: 
1. Uytdehaag, 1981 3. Taussig et aI, 1979 5. Fresno et aI, 1981 
2. Taniguchi et aI, 1980 4. Taussig & Holliman, 1979 6. Webb et aI, 1982 
16. 
it should be possible to use reductionist studies to reconstruct 
the events of help or suppression and the targets of a given 
factor in the control of various immune responses, 
2) this approach should allow the definition of the sites of MHC 
restriction in an immunoregulatory pathway, 
3) sufficient quantities of monoclonal antigen-specific factors 
will become available for purification and sequencing, as well 
as preparing cDNA probes, 
4) the therapeutic potential of these factors in allowing specific 
immune intervention are considerable. 
1.7.2 Antigen-nonspecific lymphokines 
T cell-derived antigen-nonspecific lymphokines are a heterogeneous 
population of molecules in a number of respects. They vary enormously in 
structure and function e.g. some have immunoregulatory effects and others act 
on targets outside the immune system. These lymphokines can act on T or 8 
cells, macrophages, or hematopoietic progenitor cells. Even though these factors 
act in an antigen-nonspecific manner, their production can be induced by specific 
antigens (soluble, heterologous or alloreactive). In some cases normal T cells 
have been induced to secrete lymphokines by the action of poly clonal T cell 
mitogens. T cell hybridomas and lymphoma lines have been shown to secrete 
lymphokinestonstitutively or following induction. 
A selected review of a number of important antigen-nonspecific lympho-
kines is presented below. This list is by no means complete and extensive 
reviews by Altman & Katz (1982) , and Immunological Reviews 51 (1980) cover 
these and other factors in more depth. 
1.7.2 (a) Antigen-nonspecific suppressive lymphokines 
Table 1.3 describes a number of human and murine T cell 
factors which have been demonstrated to have suppressive effects on a variety 
of immune responses. Human T cell hybridomas elaborating suppressor molecules 
will be dealt with in Section 1.8. 
It is important to note that a number of the suppressive factors presented 
in Table 1.3 appear to have effects on 8 cell responses. In many cases it has not 
been determined if these factors act on 8 cells directly or if they mediate their 
Antigen 
Human Tsr 
Soluble 
immune supp-
ressor of T 
cell proli f-
erabon 
(SISS-T) 
Soluble 
immune 
suppressor 
of 19 product-
ion 
(CTC-SISS-B) 
TABLE 1.3 
ANTIGEN - NONSPECIFIC SUPPRESSIVE FACTORS 
Derivation Assay system Comments References 
T cell hybridoma KE37 line Suppression PWM-induced B cell No suppression T-indep. 1,2 
X agammaglobulinaemic T cells di fferentiation mitogenesis, target probably 
T cell, 45 Kdal 
ConA-treated human PBL Inhibition T cell proliferative 30-45 Kdal, NAG inhibits 3 
supernatants response to mitogens & antigens activity, unstable at 56°C 
IL-2 dependent human CTl Inhibition polyclonal B cell 60-90 Kdal, binds l- 4,5 
line 19 production rhamnose, T cell product 
"'-J 
. 
Murine IgE-selective 
suppressor 
factor 
(IgE-TsF) 
Immunoglobulin 
binding factor 
(IBF) 
Released in DNP-mycobact-
erium cultures of primed 
spleen cells, T cell 
hybridoma 
In vivo alloactivated 
T cells, T cell hybridoma 
NAG N-acetyl glucosamine 
Refere~ 
1. Grillot-Courvalin et aI, 1981 
2. Grillot-Courvalin et aI, 1982 
3. Greene et aI, 1981 
4. Greene et aI, 1982 
s. Fleisher et aI, 19B1 
Suppression IgE bio- IgE &: region binding sites, 6,7 
synthesis binds IgE-specific B cells 
Suppression 1° response 38-40 Kdal 8,9 
to T-dependent &: independent 
mitogens 
6. Kishimoto et aI, 1978 
7. Suemura et aI, 19B2 
8. Gisler &: Fridman, 1975 
9. Neauport-Sautes et aI, 1979 
();j 
. 
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effects via other cells. In some instances assays were performed on enriched 
B cell populations, but the possible contribution of residual T cells or macrophages 
must not be overlooked. 
1.7.2 (b) Antigen-nonspecific T cell helper or replacing lymphokines 
T cell-derived lymphokines which augment or facilitate various 
kinds of immune responses have been induced by a variety of methods and have 
been shown to effect both humoral and cell mediated immune responses. T cell 
helper or replacing factors can be divided into a number of groups. The first 
group are closely related molecules which act specifically on T cell targets. 
IL-2 is the best characterised lymphokine in this group. The second group are 
factors which appear to act on B cell targets, either directly or via other cells 
such as macrophages. These have been termed T cell replacing factors. As the 
name implies these lymphokines can replace Th cells in antibody responses. 
Another important mediator termed allogeneic effect factor is distinct from the 
two former groups in that it displays Ia determinants. 
1.7.2 (c) Factors acting on T cells 
Models explaining the role of antigen-nonspecific lymphokines 
in T and B cell activation have been proposed (Farrar et aI, 1982). Figure 1.1 
describes one such model and the role of the lymphokine cascade in the 
amplification of antigen-specific T and B cell responses. 
T cell activation requires two signals: 
1) antigen selects the appropriate clone and induces the 
expression of receptors for growth factors and 
2) growth factors clonally expand the receptor-
expressing antigen-selected clones of effector T cells. 
B cell activation involves an analogous process: 
1) the recognition and selection of specific B cell 
clones by antigen, and 
2) the clonal expansion and maturation of these clones into 
antibody forming cells. 
FIGURE 1.1 
ROLE OF ANTIGEN - NONSPECIFIC L YMPHOKINES IN T AND B 
CELL ACTIVATION 
ANTIBODY 8-ag 
RESPONSE 
LYMPHOKINE 
CASCADE ag 
CTL 
RESPONSE 
j::i) GJ 0 ....... ab 
........... ~ (';l AFC B~---
~F vag 
(based on Farrar et 01, 1982) 
Abbreviations: 
AFC antibody forming cell ab antibody ag antigen 
CTl cytotoxic T lymphocyte rr¢ macrophage T T cell 
B B cell CSF colony stimulating factor 
IFN interferon TRF T cell replacing factor 
BCGF B cell growth factor 
The lymphokine cascade described in the centre section results from macrophages 
interacting with T cells to produce Il-l and subsequently Il-2, BCGF and TRF. 
The induction .of IFN-y production by Il-2-activated T cells is also shown. The 
upper section describes the sequential roles Il-2, BCGF and TRF in the develop-
ment of antibody responses. The lower section indicates the role of IFN-y in the 
development of CTl responses. 
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InterIeukin 2 (IL-2) 
IL-2 is a genetically unrestricted, soluble immunoenhancing 
factor produced by Th cells which have been stimulated with either T cell 
mitogens or alloantigens (Aarden et aI, 1979). A definitive assay for IL-2 
measures the ability of the factor to maintain the growth of "IL-2-addicted ll 
cytotoxic T cell lines. A number of other biological activities have been 
ascribed to IL-2; for example, the induction of thymocyte proliferation, 
augmenting the proliferation of alloantigen-stimulated T cell populations and 
inducing the synthesis of gamma interferon (Farrar et aI, 1981). IL-2 has also 
been shown to contribute a second signal to the activation of antigen-specific 
Th cells and maintaining these cells in long-term culture (reviewed by Farrar 
et 01, 1982). IL-2 has been shown to augment natural killer cell activity 
(Henney et aI, 1981). Extensive characterisation of IL-2 has been undertaken 
and human IL-2 has an apparent M W of 15 Kdal compared to 25-30 Kdal for 
murine IL-2, as assessed by AcA 54 chromatography. Human IL-2 has an 
isoelectric point of 6.5, is sensitive to protease, insensitive to DNase and 
RNase and neuriminidase and is not reduced by 2-mercaptoethanol or 
dithiothreitol. The physical properties of human and murine IL-2 have been 
investigated by Gillis and his coworkers (Gillis et ai, 1982). 
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By utilising monoclonal sources of IL-2 and cloned target cells it has been 
clearly established that IL-2 is a Tcell product, which acts on activated T cells 
(Watson et 01, 1979). IL-2 constitutes a class of closely related factors which 
serve as growth( and per haps differentiation) factors for T cells. This appears 
to result from its binding to specific receptors on the cell surface (Smith, 1980). 
Hilfiker & Farrar (1981) suggested that the process by which IL-2 signals the 
target cell to proliferate is via receptor-mediated endocytosis. Their studies 
concluded that "absorption II may be a two-step process: temperature-
independent reversible binding to the receptor followed by temperature-
dependent internalisation by receptor-mediated endocytosis. The affinity of the 
receptor has been estimated (Kd:::5 - 25 x 10- 12 M) (Robb et ai, 1981). 
1.7.2 (d) Factors acting on B cells 
(i) T cell replacing factors (TRFs) 
Dutton et al (1971) and Schimpl & Wecker (1972) first 
demonstrated that the response of T cell-depleted spleens could be restored by 
T ceU-derived mediators. This initial work utilised mixed lymphocyte cultures 
and it was soon shown that other culture supernatants of ConA or antigen-
activated T cells contained a similar factor. Functional studies of TRF led to 
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the idea that it provides a late differentiation signal to antigen-stimulated, 
proliferating B cells, which causes them to mature into antibody-secreting cells. 
A number of monoclonally-derived human and murine TRF preparations have 
recently been shown to act in a similar manner (T akatsu et aI, 1980; Kaieda et aI, 
1982; Elkins & Cambier, 1983). TRF and TRF-like molecules therefore comprise a 
heterogeneous class of B cell-specific immunoregulatory molecules which provide 
differentiation and proliferation signals to B cells at distinct differentiation stages. 
These molecules probably have a fundamental role in T -B cell collaboration by 
either turning on or shutting off B cell responses. 
(ii) B cell growth factor(s) (BCGFs) 
BCGFs have only recently been described (Howard et ai, 
1982) and probably function to deliver a proliferation signal to specific B cell 
clones which have responded to antigen and have initiated their response. BCGFs 
may therefore be involved, in combination with other activating factors, in the 
amplification of B cell antibody responses. It has been suggested that IL-2, BCGF, 
and TRF may function in a three-way synergism to augment the anti-SRBC plaque-
forming cell response to highly purified B cells {Farrar et aI, 1982}. The concept 
of a lymphokine cascade being involved in the induction of antibody synthesis is 
an attractive one and may help to explain the interrelationships between the 
various antigen-nonspecific lymphokines described here. IL-2 is involved in the 
early initiation of B cell responses indirectly, by activating some form of linked 
recognition helper function from residual T cells. Subsequently B cell proliferative 
responses begin and are amplified by BCGF. Proliferating B cells may then 
develop receptors for, and be stimulated with TRF to differentiate into antibody-
forming cells. 
(iii) Allogeneic effect factor (AEF) 
AEF is a 45 Kdal glycoprotein secreted into the super-
natants of short-term mixed lymphocyte cultures of in vivo alloantigen-activated 
T cells {Armerding et aI, 1974}. AEF-containing supernatants have also been 
demonstrated to induce naive T cells, in the absence of other exogenous stimuli, 
to proliferate and differentiate. This activity is therefore distinct from that of 
IL-2, which is also present in AEF supernatants and which provides a proliferative 
stimulus for activated T cells. Altman et aI, (1982), described the production of 
a murine T cell hybridoma which secreted high levels of AEF activity. 
1.7.2 (e) Other antigen-nonspecific lymphokines 
(i) InterIeukin-1 (IL-1) 
The macrophage-derived factor IL-1 acts in association 
with macrophages in the activation of antigen-specific T cells. Antigen-specific 
Tcell activation requires at least two distinct but interdependent macrophage 
signals. Macrophages bind, process and present antigens in an immunogenic form 
to T cells (Schwartz et ai, 1978) and the second activating signal is IL-1. IL-1 
appears to act as a maturational signal, preparing T cells to respond to antigen 
or secondary signals. IL-1 also induces the synthesis and secretion of IL-2 
(Smith et ai, 1980). The link between IL-1 and IL-2 is essential in T cell 
activation because it is the conversion of a primary macrophage-derived signal 
into a secondary T cell-derived proliferative signal that results in the amplificat-
ion of specific immune responses. Gery et al (1972) first described IL-1, at that 
time termed lymphocyte activation factor, which was mitogenic for thymocytes. 
IL-1 has also been demonstrated to have effects on non-T cells. Schroder {1973} 
showed that macrophages produced a soluble factor which could restore the 
in vitro antibody responses of spleen cells from congenitally athymic nude/nude 
mice. Wood & Gaul (1974) used an experimental system of T cell-depleted 
(anti-Thy 1 treated) spleen cells from normal mice and demonstrated a similar 
effect. In both studies the authors concluded that the macrophage product was 
acting directly on the antibody producing B cell. Wood et al (1976) termed this 
activity B cell activating factor. The nomenclature for IL-1 was clarified in 
1979 (Aarden et al), and IL-1 is now considered to be synonymous with lymphocyte 
activating factor, B cell activating factor, thymocyte proliferation factor and 
B cell differentiation factor. 
Murine IL-1 has been purified to apparent homogeneity (Mizel & Mizel, 
1981 a) and has been demonstrated to be a 12-15 Kdal protein with high affinity 
for hydrophobic resins that exhibits resistance to several proteases. This unusual 
stability of IL-1 indicates that it probably exists in a compact form in its native 
configuration. This may have phYSiological significance as there is considerable 
evidence that IL-1 may be involved in inflammatory responses, which are known 
to cause the release of a number of proteases into the inflammatory site (Mizel 
et ai, 1981b). The biochemical and immunological effects of IL-1 have been 
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reviewed (Mizel, 1982). 
(ii) Interleukin 3 (IL-3) 
The term IL-3 was first introduced by Ihle et ai, (1981) 
to describe a factor responsible for the induction of the enzyme 20a-steroid 
dehydrogenase (20a-SDH) in cultures of murine nude/nude splenocytes. Unlike 
IL-2, IL-3 primarily influences a stage or stages of immature lymphocyte 
differentiation. This view is disputed by Watson & Prestige (1983), who feel 
IL-3 is not merely an activated T cell product as it has been shown to be 
produced by the myelomonocytic leukemia line WEHI-3 among others (Ihle et aI, 
1982). A variety of colony-stimulating activities have been associated with 
preparations of IL-3 and the question has been raised whether IL-3 and a class 
of colony-stimulating factors are in fact the same. Sequential purification of 
IL-3 using gel chromatography, ion exchange chromatography and reverse phase 
high performance chromatography appears to copurify these activities. The 
apparent MW of IL-3/CSF is 41 Kdal on sodium dodecyl sulphate electrophoresis 
and the apparent dissociation constant of the molecule in inducing 20a-SDH 
activity has been estimated at 10- 1 1M. The debate whether IL-3 and multi-
CSF (WEHI-3-derived IL-3) are the same, and whether IL-3 is predominantly a 
regulator of hematopoietic differentiation or a mediator of immune modulation, 
will continue and may be answered when detailed biochemical analyses of these 
molecules are performed. 
(iii) Interferons (IFNs) 
The interferons are a heterogeneous protein family 
produced by a variety of cell types. Originally the IFNs were defined as 
proteins which exert virus-nonspecific antiviral activity, but they are now 
regarded as important mediators of the immune response as they can induce 
both enhancing and suppressive effects. The IFNs have been categorised into 
two groups. Type 1 (IFN-a and IFN- B) consists of virus-induced IFN and those 
induced by specific agents. Type 1 or "classical" IFN has been observed to 
suppress both primary and secondary antibody responses to T -dependent and T-
independent mitogens and antigens. IFN-a. has also been shown to suppress the 
proliferative phase of a human mixed lymphocyte reaction. Type 2 IFN (IFN-y) 
is produced by a populat ion of T cells which are macrophage-dependent. 
Because IFN-y is produced during antigen or mitogen stimulation of T cells 
(which also causes the production of other lymphokines) it has been difficult to 
ascribe a given immunaregulatary activity ta IFN-y. A number af T cell lines 
and hybridomas have been shown to produce IFN-y (reviewed by Krakaeur & 
Clough, 1981). 
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A summary of the various antigen-nonspecific factors discussed in the 
preceeding section, as well as factors acting on macrophages, are presented in 
Table 104. 
1.8 HUMAN T CELL HYBRIDS 
1.8.1 General introduction 
As mentioned, and evidenced by the preceding review, the closer 
investigation of these lymphokines has been hampered by the presence of 
heterogeneous lymphokine species in conventional culture supernatants. Cloned 
T cell lines therefore have the advantage that such heterogeneity can be 
reduced to an extent. This problem of multiple secretion of lymphokines is not 
as great with T cell lines which secrete antigen-nonspecific lymphokines. These 
lines do not appear to produce specific lymphokines, and secondly, if they did, 
it would be relatively simple to purify the antigen-specific lymphokine by affinity 
chromatography on immunoadsorbents coated with the relevant antigen. It may 
be more difficult, in the case of antigen-nonspecific lymphokine-producing cells, 
to achieve separation between distinct molecular species. Methods therefore 
which favour a more restricted pattern of lymphokine production would be 
valuable. 
The work presented in this thesis addresses this problem by utilising 
somatic cell hybridisation techniques for the production of human regulatory 
lymphokines. Table 1.5 presents a number of human T cell hybridomas 
recently described in the literature. It is evident from this summary that little 
biochemical analysis of the hybridoma-derived factors have been undertaken. 
These deficiencies will no doubt be rectified in the near future and a better 
understanding of the physical and chemical nature of these mediators will 
result. 
Factor(s) 
Interleukin Z (Il-Z) 
T cell replacing 
factor (TRF) 
B cell growth factors 
(BCGFs) 
Allogeneic effect 
factor (AEF) 
Interleukin I (Il-l) 
Interleukin 3 (IL-3) 
Derivation 
Stimulated Th cells 
MlC cultures 
Activated T cells 
Short-term MlC 
cultures 
u¢ 
Activated T cells, 
WEHI-3 line 
1.4 
OTHER ANTIGEN - NONSPECIFIC FACTORS 
Target cell(s) 
T cells 
B cells 
B cells 
Induces naive T cell 
proliferation 
T cells in association with 
u¢ 
T cells, hematopoietic 
progenitor cells 
Comments 
Activated-T cell growth factor, 
Murine 25-30 Kdal, Human 
15 Kdal 
late differentiation signal to 
antigen-stimulated, proliferat-
ing T cells 
Proll feration to specific 
activated B cell clones 
45 Kdal glycoprotein 
T cell maturational signal, 
induces IL-2 secretion, murine 
IL-l 12-15 Kdal, 
Induces zoa SDH activity 
References 
1 
2,3 
4 
5 
6,7 
8,9 
N 
().. 
Interferons (IFNs) Variety cell types 
Macrophage activating Activated T cells 
factor (MAF) 
Macrophage inhibitory Activated T cells 
factor (MIF) 
MLC 
2m SOH 
mixed lymphocyte culture 
20-alpha steroid dehydrogenase 
isoelectric point 
LK lymphokine 
References: 
L Gillis et aI, 1982 4. 
2. Dutton et aI, 1971 5. 
3. Schimpl & Wecker, 1972 6. 
T cells, other cell Antiviral activity, induces 10 
types? other LK production 
~ Induces m¢-mediated 11,12 
tumoricidal activity, ~0-55 
Kdal, pH 4 inactivatlon, 
56°C inactivation, pI = 4.~ 
Inhibits m¢ migration 0.1M L-fucose inactivation 13 
Farrar et aI, 1982 7. Mizel & Mizel, 1981 10. Krakaeur & Clough, 1981 
Armerding et aI, 1974 8. Ihle et aI, 1981 11. Screiber et aI, 1982 
Gery et aI, 1972 9. Ihle et aI, 1982 12. Screiber et aI, 1983 
13. Pick et aI, 1979 
Functional properties 
of Hybrids and (or) 
factors 
Suppression B cell 
di fferentiation 
MIF & LT 
Inhibition PWM-induced 
19 production, no inhib-
ition lectin or antigen-
induced T cell prolifer-
ation 
IgA-specific 11elp, PC B cell 
activation, U cell prolifer-
ation 
Constitutive BCGF product-
ion in absence Il-2 
TABLE 1.5 
HUMAN T CELL HYBRIDS AND DERIVED FACTORS 
Assay systems 
PWM induced B cell 
di fferentiation 
MIF & LT 
PWM-induced Ig, lectin 
& antigen induced T cell 
proli feration 
Induction Ig, B cell 
proliferation 
1l-2 CTC line prolif-
eration, BCGF purified 
& activated B cell if-
eration 
Parental tumor 
line 
KE37 (TK-) 
Emetine & actinomycin 
D treated CEM 
CEM (HGPRT-) 
J3 (HGPRT-) 
KE37 (HGPRT-) 
CEM-6 (HGPRT-) 
T cell partner 
& activation 
regime 
Unstimulated agammaglob-
ulinaemic T cells 
Normal PBl, 40 hr PHA-
P (5)Jg/ml) 
Normal PBl, 4B hr ConA 
(lO)Jg/ml) 
90-95% OKT4+, 72 hr 
ConA ClO)Jg/ml) 
AET-rosetted normal 
T cells, 24 hr ConA 
(lO)Jg/ml) 
Comments 
No suppression to 
T-independent 
mitogens, 45 Kdal 
Producer clone 
phenotype no 
biochem. analysis 
70-85 Kdal, B cell 
or m¢ target 
No biochem. analysis 
18-20 Kdal 
References 
1,2 
3,4 
5 
6 
7 
N 
co 
. 
Constitutive Il-2, MGF & 
IFN-y production 
Constitutive Il-2 
secreting clones, also after 
m¢ or PHA treatment, 
KHF clones 
Tetanus toxoid-specific 
hybrids produce Il-2 
after mitogen or antigen 
stimulation 
Several Th clones 
Il-2 : PHA-stimulated 
PBl proliferation 
Il-2: CTC line prolif-
eration, KHF : helper 
activity of culture 
supernatant in eTC 
di fferentiation 
HUT 102-B2 
(HGPRT-) 
CEM (HGPRT-) 
Il-2 : CTll proliferation Jurkat 6TG-3 
Helper activity : T hybrid 
binding to pre pulsed m¢ 
Hybrid cell induction or 
regulation of PWM-induced 
Ab production 
Normal PBL, 48 hr 
ConA (lOjJg/ml) 
E-rosetted normal T 
cells, Con A (lOjJg/ml) 
or MLC T cells 
TeT-specific T cell 
lines 
E-rosetted normal T 
cells, 96 hr PHA 
(lOjJg/ml), 192 hr PWM 
(5jJg/ml), 48 hr eonA 
(2jJg/ml) 
All producing hybrid-
omas Th 
No biochemical analysis 
Parental activity 
retained by hybrid 
Functional activity 
recovered after 
cloning 
8 
9 
10,11 
12 
" '< 
. 
Il-2 production by 48 hr stimulation 
EBV-reactive hybrids 
MIF macrophage inhibitory factor 
L I lymphotoxin 
CTC IL-2-dependent cytotoxic T cell line 
AET 2-aminoethylisothiouronium 
MGF mast cell growth factor 
References: 
1. Grillot-Courvalin et aI, 1981 
2. Grillot-Courvalin et aI, 1982 
3. Kobayashi et aI, 1982 
4. Asada et aI, 1983 
5. Greene et aI, 1982 
6. Mayer et aI, 1982 
7. Butler et aI, 1983 
Jurkat EBV-immune PBls, 9 d No biochemical 
LCL stimulation analysis 
KHF killer helper factor 
CIll murine 1l-2-dependent cytotoxic r cell line 
E rosetted SRBC receptor positive 1 cells 
EBV Epstein-Barr Virus 
lCL lymphoblastoid cell line 
8. Le et aI, 1983 
9. Okada et aI, 1981 
10. DeFreitas et aI, 1982a 
11. DeFreitas et aI, 1982b 
12. lrigoyen et aI, 1981 
13. Lakow et aI, 1983 
13 
w 
o 
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1.8.2 Techniques for the production of human T cell hybrids 
1.8.2 (a) Int rod uct ion 
The successful production of hybridomas secreting 
monoclonal antibodies has had a dramatic effect on modern immunology. Okada 
(1962) first described the phenomenon of cell fusion mediated by Sendai Virus. 
Modifications of these early techniques are now widely used to produce highly 
specific immunological reagents. 
A similar rationale is used in producing T cell hybrids with specific functions 
deriving from the parental T cells. The expectation therefore, is that specific 
T cell functions will continue to be expressed within the background of the 
proliferating T cell lymphoma. 
T cell hybrids have applicability in a number of areas of immunology. One 
application has been analysis of the antigen-recognising structures on T cells i.e. 
T cell receptors (Rajewsky & Eichman, 1977). The assumption here is that T cell 
hybrids will be obtained that secrete homogeneous factors which bind membrane 
antigens specifically. 
T cell hybridisation has also been applied to the analysis of the origin of 
genetic restdctions in cell interactions. It is widely believed that T cells 
recognise antigen in "association ll with self cell surface components. Presumably, 
T cell hybrids exhibiting antigen restricted recognition should allow a more 
elegant analysis of this problem than by using heterogeneous T cells. 
The third important use of T cell hybrids is in the study of T cell secretory 
activity. Recently, several laboratories have been successful in constructing 
human T cell hybrids expressing T cell function of the nonlymphoma partner as 
evidenced by the secretion of soluble mediators of immune responses (Table 1.5). 
Spontaneous fusions of cells in culture are infrequent, but if this does occur, 
it is still difficult to identify the hybrids arising from these fusions. 
Improved fusion techniques and selection systems for cell hybrids have 
overcome many of these early difficulties. In the case of human T cell hybrids, 
the hybridisation technique involves mixing a suspension of antigen-or mitogen-
activated T cells with a selected T lymphoma line. The T cells are fused with 
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polyethylene glycol. A selection system is used to eliminate the parental cells 
and to permit growth of the hybrids. The primary non-neoplastic parent dies 
after a limited period in culture. Elimination of the lymphoma parent is 
accomplished usually by a drug selection system. The most frequently used 
drug selection system is tissue culture medium supplemented with hypoxanthine, 
aminopterin and thymidine (HAT) as devised by Szybalski et al (1962). This 
selection system relies upon the fact that cells deficient in either hypoxanthine 
guanine phosphoribosyl transferase (HGPRT) or thymidine kinase (TK) die in the 
presence of aminopterin. Hybrids that have inherited complementary unaltered 
HGPRT and TK genes from two parents are able to grow (Littlefield, 1964). 
1.8.2 (b) Selection of purine and pyrimidine analogue resistance in 
mammalian cells 
Somatic cell hybridisation takes advantage of purine and 
pyrimidine analogue resistance. Variant-resistance to these analogues initially 
represented important and technically useful markers which were used to 
characterise permanent cultured cell lines. The usefulness of these variants 
results from several properties: 
1) 8-azaguanine (AG) and 6-thioguanine (TG) in many cases 
selects for the loss of the enzyme HGPRT, which is 
controlled by an X-linked hemizygous gene (Shows & 
Brown, 1975), 
2) purine and pyrimidine nucleosides are relatively stable 
substances which occur in limited concentrations in the 
serum and are not liberated by the breakdown of serum 
components. Competition between analogues and their 
natural correlates is therefore not a significant problem 
(Peterson et ai, 1976), 
3) the mutation rates in these variants is low enough (in 
either direction) to allow their study (Morrow, 1970), 
4) mammalian cells are not usually prototrophic for purines 
and pyrimidines and their addition to the medium is not 
required for cell survival. 
Drug resistant cells arise spontaneously in culture, but the use of X-rays 
(Albertini & DeMars, 1972) ar chemical mutagens such as ethyl methane 
sulphonate (EMS), greatly increases the mutation rate. After exposure to 
mutagens, drugs such as azaguanine (Sato et aI, 1972) and thioguanine 
(Van Zeeland et aI, 1974) kill normal cells because the drugs are metabolised 
and interfere with nucleotide and nucleic acid synthesis. This effect is 
mediated by the enzyme HGPRT which converts the drugs to abnormal nucleo-
tides. Mutants which lack the HGPRT enzyme (HGPRT-) are resistant to AG 
or TG and therefore survive the treatment. A number of purine and pyrimidine 
nucleoside analogues can be used in the selection af drug-resistant variants. 
Some of these are presented in Table 1.6. There appears to be a large 
variation in the ease with which drug-resistant mutants can be isolated from 
different cell lines. This variation may result from differences in the number 
of copies of the gene present in the cell line, or could be due to suppression 
or inactivation of the gene (Morrow, 1977). 
1.8.2 (c) Principle of HAT selection system 
Purine and pyrimidine nucleotide biosynthesis in mammalian 
cells is achieved via endogenous (de novo) pathways or via salvage pathways in 
times of stress or starvation in the cell. When the de novo biosynthetic pathways 
for purine and pyrimidine nucleotides are blocked by the folic acid analogue 
aminopterin (Figure 1.2), normal cells (HGPRT+, TK +) can bypass this block and 
utilise preformed hypoxanthine and thymidine to synthesise nucleic acid precursors 
via their respective salvage pathways. Somatic cell variants lacking these salvage 
enzymes (HGPRT-, TK-) cannot survive because they are unable to synthesise 
nucleotides from hypoxanthine (HGPRT- cells) or from thymidine (TK- cells) 
(Littlefield, 1964). 
Aminopterin acts as a stoichiometric inhibitor of folic acid reductase 
(Littlefield, 1969). Aminopterin has also been shown to block the endogenous 
synthesis of purines, one-carbon-transfer reactions, and the synthesis of certain 
amino acids. Littlefield (1964), demonstrated that the HAT medium as well as 
being able to screen for rore revertants of HGPRT- mutants to HGPRT+ cells, 
was also extremely useful if selecting for somatic cell hybrids derived from 
parents lacking HGPRT and TK activity. While parental (HGPRT-) tumor cells 
are killed by HAT, only hybrids that have inherited complementary unaltered 
HGPRT and TK genes from two parents are able to grow. This selection system 
has been used almost exclusively for the selection of B cell hybridomas as well 
as human T cell hybridomas. Several modifications of this system have been 
TABLE 1.6 
PURINE AND PYRIMIDINE NUCLEOSIDE ANALOGUES USED IN 
THE SELECTION OF DRUG-RESISTANT VARIANTS 
34. 
Analogue Natural 
correlate 
Enzyme involved 
in resistance 
References 
6-thioguanine (6TG) Guanine HGPRT 
8-azaguanine (8AG) Guanine HGPRT 
5-bromodeoxyuridine (BUdR) Thymidine TK 
2,6-diaminopurine Adenine APRT 
6-azauridine Uridine UK 
HGPRT 
TK 
APRT 
UK 
hypoxanthine guanine phosphoribosy1 transferase 
thymidine kinase 
References: 
adenine phosphoribosy1 transferase 
uridine kinase 
1. Sharp J.D., Capecchi N. & Capecchi M. (1973) PNAS USA 70, 3145. 
2. Morrow J. (1970) Genetics 65, 279. 
3. Kit S., Dubbs D.R., Piekarski L & Hsu LC. (1963) Exp. Cell. Res. 31, 297. 
4. Chasin L.A. (1974) Cell 2, 37. 
5. Vesely J. & Cihak A. (1973) Oncology 28, 204. 
1 
2 
3 
4 
5 
used to overcome a number of problems e.g. aminopterin toxicity, and 
cellular variations in nucleic acid metabolism, which can all affect the 
efficiency of HAT selection. Azaserine, an inhibitor of several amido 
transferases, has been used with hypoxanthine to block endogenous purine 
synthesis in the selection of hybrids (Siniscalco et ai, 1969). 
FIGURE 1.2 
PRINCIPLE OF HAT SELECTION SYSTEM 
De novo biosynthesis pathways for: 
Salvage pathways: 
Hypoxanthine 
Guanine + PRPP 
HGPRT RIBONUCLEOT IDES __ .. ~. RNA 
Thymidine + ATP TK DEOXYRIBONUCLEOTIDES 
--.. ~~ DNA 
Purine and pyrimidine biosynthesis is achieved via de novo pathways, or via salvage 
pathways in times of stress. If the de novo biosynthetic pathways are blocked by 
+ + 
aminopterin, normal cells (HGPRT , TK ) are able to bypass this and utilise preformed 
hypoxanthine and thymidine to synthesise nucleic precursors via their respective 
salvage pathways. Cells lacking these salvage enzymes (HGPRT-. TK-) do not survive as 
they are unable to synthesise nucleic acid precursors. 
1.8.2 (d) Phenotypic selection of hybrids 
As the HAT selection system can only be used with mutant 
tumor lines deficient in certain enzymes, it would be of value to have other 
selection systems to ensure true hybrids are produced. Taniguichi & Miller 
(1978) devised a selection method using the fluorescence activated cell sorter 
which enabled non-mutant T cell lines to be used in T cell hybridisation 
programmes. This allowed the separation of cells stained with fluorescent 
antibodies directed against cell-surface components present only on normal 
T cells, and, presumably, also expressed by any hybrid cells resulting from 
J:>. 
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the fusion of normal and tumar cells. Dangl & Herzenberg (1982) discussed the 
use of fluorescence activated cell sorting for B cell hybridomas which substant-
ially eased the process of isolating stable hybridomas, or selecting hybridoma 
variants with desired structural and functional properties. 
1.9 CONCLUSIONS 
From this literature review it is evident that litt Ie of the structural 
nature of human regulatory lymphokines is ,known despite their extensive 
characterisation in biological assay systems. These shortcomings in our know-
ledge are due primar ily to the lack of homogeneous T cell lines producing 
restricted numbers of T cell regulatory lymphokines. The following sections of 
this thesis are directed to the problem of developing in vitro techniques for the 
production and assaying of human lymphokines which affect antibody responses. 
Somatic cell hybrids have been used as a source of these lymphokines. 
CHAPTER 2. 
MA TERIALS AND METHODS 
2.1 CELL CULTURES AND CRYOPRESERVA TION OF CELL LINES 
2.1.1 Peripheral blood lymphocyte (PBL) isolation 
Heparinised (Upjohn, U.K.) venous blood samples from healthy 
hospital workers were diluted 1:2 with sterile phosphate buffered saline (PBS) 
pH 7.4 and centrifuged on Ficoll-Hypaque (Boyum, 1968),25ml 1:2 diluted blood 
was layered onto 15ml Ficoll-Hypaque (6 = 1.077g/ml) and centrifuged at 400g 
for 25 minutes. Mononuclear cells from the interface were recovered with a 
sterile pasteur pipette, washed twice in serum-free tissue culture medium, and 
counted using a hemacytometer by dye exclusion (0.1 % eosin). Lymphocyte 
isolations and cell cultures, were in all cases performed using standard "sterile 
techniques" in either a Laminar-Flow (Clemco, Aust) or Biohazard (Clemco) 
tissue culture hood. 
2.1.2 Tissue culture medium 
Cell cultures were performed in RPMI 1640 medium (GIBCO, Cat. 
37. 
No. 430-1800) containing 25mM HEPES (Research Organics, Ohio) supplemented 
with 100 U/ml penicillin (Glaxo, U.K.), 100 lJ.g/ml streptomycin (streptomycin 
sulphate, Glaxo, U.K.), 4mM additional L-glutamine (Sigma) and heat-inactivated 
(56°C, 60min) foetal calf serum (FCS) (GIBCO) at 10,15 or 20% as indicated. 
Cell cultures were incubated at 37°C in a 5% CO2 atmosphere in a water jacketed 
incubator (Forma SCientific) with 100% relative humidity. Disposable plastic 
tissue culture ware was used as described. 
2.1.3 Cryopreservation of cell lines 
At regular intervals, stocks of the cell lines were frozen in case 
contamination or chromosomal instability, leading to the death of the line 
occurred. Cells to be frozen were chilled on ice for 30m ins (approx. lOx 10 6 
cells in O.5ml RPMI, 20% FCS) in 2ml cryopreservation tubes (Nunc). 0.5ml ice 
cold FCS, 20% dimethyl sulphoxide (v/v) (Sigma) was then added dropwise with 
mixing. The cryopreservation tubes were frozen overnight in a -70°C Revco 
freezer in an upright position. Next day the ampoules were transferred to a 
Linde (LR-40, Union Carbide, USA) liquid nitrogen cryopreservat ion container. 
When required, cells were rapidly thawed in a 37°C water bath and 
diluted dropwise with ice cold RPMI (20 volumes) over approximately 5 mins. 
These thawed cells were washed twice with RPM I and resuspended in tissue 
culture medium with the relevant supplements. If low cell viabilities were 
evident (by dye exclusion) the thawed cells were centrifuged over Ficoll-
Hypaque to remove the non-viable cells, and then cultured. 
2.2 CONSTRUCTION AND SELECTION OF HUMAN T CELL HYBRIDS 
2.2.1 Introduction 
Human T cell hybr ids were constructed between normal lectin-
activated peripheral blood lymphocytes and a 6-thioguanine resistant (TGR) 
subline of the human T cell acute lymphocytic leukemia (T -ALL) line CCRF-
CEM. Polyethylene glycol (PEG) was used as the fusigen and T cell hybrids 
were subsequently selected using HAT-supplemented tissue culture medium 
and flow cytometric selection by sterile cell sorting on a Fluorescence 
Activated Cell Sorter. 
2.2.2 Drug-resistant parental T cells 
A 6-thioguanine resistant (HGPRT deficient) subline of the 
CCRF-CEM (Foley et aI, 1965) T -ALL line was established after mutagenesis 
with ethyl methane sulphonate (EMS) and subsequent selection in 6-thioguanine 
supplemented tissue culture medium. 
CCRF-CEM was established in 1965, from the peripheral blood of a 
three year old female child with acute lymphocytic leukemia. This line has 
been extensively characterised (Foley et aI, 1965; McCarthy et aI, 1965; 
Schachtschabel et aI, 1966; Suomalainen et aI, 1980) and various drug-
resistant subclones of this line have been used as a parental tumor line for 
the construction of human T cell hybrids (Table 1.5). 
Exponentially growing CCRF-CEM cells (5 x lOs /ml) were mutagenised 
with varying concentrations of EMS (Sigma) (1,5,10 or 50\.lg/ml) for 24 hrs at 
38. 
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37°C in a 5% CO2 atmasphere (based on the methods of Sato et aI, 1972; 
Epstein et aI, 1977). Surviving cells were plated directly into 96-well round-
bottomed microtitre plates (Nunc),1000 cells/well, in supplemented RPMI 1640, 
15% FCS and O.l11g/ml 6-thioguanine (6TG) (Sigma). Wells exhibiting growth 
were expanded into tissue culture flasks (Nunc) and the 6TG concentration 
was increased stepwise up to 1811g/ml over the next 6 weeks. The cultures 
were fed every 3-4 days by aspirating approximately half the spent medium 
and replacing it with fresh 6TG-supplemented tissue culture medium. A line 
of rapidly growing, mutagenised CCRF-CEM cells, (CEM-6TGR), resistant to 
1811g/ml 6 TG was established in this manner and maintained in 6 TG-supple-
mented tissue culture medium, 15% FCS. At regular intervals aliquots of cells 
were frozen and stored in liquid nitrogen (Section 2.1.3). 
A number of functional and phenotypic characteristics of the CCRF-CEM 
and mutagenised CEM-6TGR lines were assessed. These studies included: 
1) Growth rate Section 2.2.3 
2) Terminal deoxynucleotidyl 
transferase staining Section 2.2,4 
3) HAT sensitivity Section 2.2.5 
4) Cell surface phenotype Section 2.3 
5) Karyotype Section 2.4 
6) Functional HGPRT activity Section 2.5 
2.2.3 Growth rate 
Replicate 10ml cultures of CCRF-CEM or CEM-6TGR cells were 
seeded at 1 x 104/ml or 1 x 10 5/ml (> 90% viable) in RPMI, 15% FCS (CEM-
6TGR supplemented with 1811g/ml 6TG) at time O. At various intervals a 
replicate cell culture was harvested by centrifugation and a total and viable 
cell count was performed. In general, twelve hemacytometer fields were 
counted and the average viable numbers/ml was calculated. The doubling 
times of the cell lines was estimated from a plot of log viable cell number/ml 
versus time in culture. 
2.2,4 Terminal deoxynucleotidyl transferase (TdT) staining 
T dT is a DNA polymerase which is recognised as a "marker" 
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for primative lymphocytes in the hematopoietic system (Janossy et aI, 1979). 
Fixed ce lIs were treated with a specific rabbit ant i-bavine T dT ant ibody. 
Fluorescent staining af the immune complex with FITC labelled goat anti-rabbit 
IgG was used to visualise the percentage T dT+ cells. The technique used was 
that recommended by the manufacturer (Biotech Research laboratories, Inc, 
Rockville, MD. Product No. 9331 SA). 
2.2.5 HAT sensitivity 
Growth of the CEM-6TGR line in 6TG-supplemented medium 
suggested it was deficient in the salvage enzyme hypoxanthine guanine phospho-
ribosyl transferase (HGPRT, EC 2.4.2.8) (Sato et aI, 1972; Van Zeeland et ai, 
1974). Cell lines deficient in HGPRT activity are killed in HAT medium 
(Szybalski et aI, 1962) and this was assessed directly by culturing cells (5 x 10 5 
Iml, >90% viable) in hypoxanthine (0.1 mM), aminopterin (O.4JlM), thymidine 
(16JlM) (HA T)-supplemented RPMI, 15% FCS. Every 2 days the cells were 
5 
counted and recultured at a viable density of 5 x 10 Iml. 
2.2.6 Other parental lines 
An 8-azaguanine resistant sub line of CCRF-CEM (CEM-AGR), 
kindly provided by Professor T. Kishimoto (Dept. Medicine, Osaka Univ. Hosp, 
Osaka, Japan) was also used in some fusion experiments. This line has been 
used to generate functional human T cell hybrids (Okada et aI, 1981). CEM-AGR 
was assessed for growth rate (Sect ion 2.2.3) and cell surface phenotype 
(Section 2.3). 
2.2.7 Activation of normal T cells 
Freshly isolated human PBls (Section 2.1.1) were activated for 
either 2 or 5 days with 10Jlg/ml Concanavalin A (ConA) (Sigma) at 1 x 106/ml 
in supplemented RPMI, 10% FCS. Samples of these activated cells were 
stained by indirect immunofluorescence to determine the percentage T and B 
cells (Section 2.3) and the remaining cells were fused with the CEM-6TGR line. 
2.2.8 Fusion procedure 
The method used was based on that of Grillot-Courvalin et aI, 
(1981). Equal numbers of ConA-activated PBls and CEM-6TGR cells 
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(8 x 106 to 15 x 10 6 of each, in 4 separate experiments) were mixed and 
centrifuged at 1000g for 5 minutes, washed once in warm RPMl (37°C) and a 
second time in warm RPMI containing 5% (v/v) dimethyl sulphoxide (DMSO) 
(Sigma); to enhance the polyethylene glycol (PEG) mediated cell fusion (Norwood 
et aI, 1976). The pellet was gently resuspended in lml warm 50% (v/v) PEG 4000 
(Sigma) which was added dropwise over approximately one minute. After gentle 
mixing for a further minute the cells were centrifuged at 500g for 3 minutes, 
the supernatant was removed and 20mls warm RPMI was added dropwise. The 
cells were centrifuged and again washed. These fused cells were suspended in 
RPMI supplemented with HAT, 20% FCS and plated at a density of 1 x 106/ml 
in 96 well flat-bottomed microtitre plates (Nunc) in a volume of 200'111, 
cultured at 37°C and fed every 2-3 days. 
2.2.9 Drug selection of hybrids 
Though the standard HAT medium is widely used to select for 
successful hybrids it has been reported that the thymidine component causes 
growth inhibition of the CCRF-CEM line (Schachtschabel et aI, 1966; Fox et aI, 
1981). An alternative selection medium utilising azaserine and hypoxanthine 
(AH) (Siniscalco et aI, 1969) was used to select for putative hybrids from a 
fusion exper iment. 15 x 10 6 48 hr ConA-activated PBls were fused with 
15 x 106 CEM-AG R cells as described above. These fused cells were plated at 
1 x 106 Iml in 96 well flat-bottomed microtitre plates in either HAT medium, 
20% FCS or azaserine (Sigma) (1 'I1g/mI) and hypoxanthine (0.1 mM), 20% FCS and 
fed every 2-3 days. After 14 days the cells were conditioned through HT 
medium (no aminopterin), 20% FCS or H medium (no azaserine), 20% FCS for 
the respective plates, for 14 days, then into tissue culture medium lacking anti-
metabolites. At 30 days post-fusion the number of wells containing viable cells, 
as assessed by direct microscopic examination, were counted. This estimate of 
the numbers of wells containing viable cells was used to compare the 2 drug 
selection systems. 
2.3 SURF ACE MEMBRANE STAINING AND FLUORESCENCE ACTIVATED 
CEll SORTING 
2.3.1 Introduction 
The fluorescence activated cell sorter (FACS) (Becton-Dickinson 
F ACS Systems, Sunnyvale, California) is an instrument which enables both the 
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rapid analysis of cell populations and the physical separation of selected cell 
subpopulations. The FACS allows large numbers of cells to be analysed on a 
cell-by-cell basis, is highly sensitive to fluorescence signals (e.g. fluorochrome-
labelled cell populations), allows the objective interpretation of cell population 
data, and in addition, allows the sterile collection of specific cell subpopulations. 
Analysis of individual cells results from the sample passing down a sterile 
saline stream which is intersected, at right angles, by a focussed argon laser. 
When the laser strikes a cell in the stream, the cell emits a number of signals, 
each of which is characteristic of that cell. These signals con be: 
1) fluorescence; resulting from either cell autofluorescence 
or fluorochrome-labelled antibodies which have been bound 
to specific cell surface receptors, or 
2) light scatter; resulting from reflection, refraction and 
diffraction of laser light striking the cell. The magnitude 
of the scatter signal is determined primarily by cell size i.e. 
larger ce lIs in general scatter more light. 
To phYSically sort cells, the operator sets ranges for each signal into which 
a cell must fall to be sorted. By vibrating the fluid stream at high frequency 
it breaks into well defined drops. By charging the stream just as the required 
cell is about to become part of a drop it is given a charge which causes it to be 
deflected further on as it passes through a constant electric field. Depending 
on the charge given, it is deflected to either the left or right, and the desired 
cell can be collected. 
2.3.2 Analysis of data 
As each cell is analysed, four separate signals are generated, one 
for scatter, two for fluorescence and one representing a ratio of any two signals. 
2.3.2 (a) Single parameter display of data 
This method of display consists of histograms of two 
selected parameters, in this case scatter and fluorescence (Figure 2.1). The 
horizontal axis is the intensity of the signal and the vertical axis is the 
relative number of cells at each intensity of signal. 
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FIGURE 2.1 
SINGLE PARAMETER DISPLAY OF FACS DATA 
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A. Histogram of light scatter (horizontal axis) versus relative number of cells at 
each intensity of signal (vertical axis). Peak I : debris, cell fragments etc; 
Peak 2 : small cells; Peak 3 : large cells. 
B. Histogram of log fluorescence (horizontal axis) versus relative number of cells 
at each intensity of signal (vertical axis). Peak 4 : non fluorescing cells; 
Peak 5 : fluorescent cells. 
2.3.2 (b) Dual parameter display of data 
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Single parameter histograms unfortunately do not allow the 
correlation between parameters to be expressed i.e. one cannot infer what peak 
(s) on the scatter histograms belong with what peak(s) on the fluorescence 
histogram. Dual parameter or three dimensional displays overcome this problem 
as each horizontal axis represents a signal strength of one of the selected 
parameters and the vertical scale gives the number of cells with that combination 
of signal amplitudes. Figure 2.2 represents a typicol display using dual 
parameter analysis. 
FIGURE 2.2 
DUAL PARAMETER DISPLAY OF FACS DATA 
Dual parameter display of peripheral blood lymphocytes stained with a reagent directed 
against surface membrane immunoglobulin (Smlg)j causing B cells to fluoresce. 
The profiles of scatter versus log fluorescence are shown. The height of each peak 
indicates the relative number of cells at each intensity of signal. 
2.3.2 (c) Gated anal ys is 
This analysis method overcomes many of the problems 
inherent in single parameter analysis. Two ronges ore set, into which a cell 
must fall, before it is counted and displayed on a histogram. For example, if 
one wishes to investigate the fluorescence distribution of lymphocytes this is 
achieved by gating on the part of the scatter histogram which corresponds to 
the lymphocytes and then display the resulting fluorescence histogram 
(Figure 2.3), 
44. 
The use of highly specific, fluorochrome-labelled, monoclonal antibodies to 
human cell surface receptors, in conjunction with FACS analysis and sorting, are 
powerful techniques which can be used for the quantitation and isolation of 
specific T cell subpopulations depending on the particular antigen array they 
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express on their cell membranes. 
FIGURE 2.3 
GA TED DISPLAY OF F ACS DATA 
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This figure describes the use of gating for the analysis of cell distributions. 
A. Ungated fluorescence profile of peripheral blood mononuclear cells stained 
with a monoclonal antibody which identifies: Peak I: lymphocytes; 
Peak 2 : monocytes. 
B. Scatter distribution of cells falling in the low positive fluorescence peak 
(Histogram A, peak 1). 
c. Scatter distribution of cells falling in the high positive fluorescence peak 
(Histogram A, peak 2). 
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2.3.3 Monoclonal antibodies (McAbs) to human cell surface receptors 
The membrane phenotype of the parental tumor lines (CEM-6TGR, 
CEM-AGR) was determined by using a wide range of McAbs to human cell 
surface receptors. This approach aimed to use the membrane phenotype as a 
method to select hybrids in conjunction with the usual drug selection. The 
McAbs used, and the cell antigens or subpopulations they define are presented 
in Table 2.1. The indirect immunofluorescence staining technique is presented 
in Section 2.3.4. 
2.3.4 Indirect immunofluorescence staining using monoclonal antibodies 
Indirect immunofluorescence staining using murine monoclonal 
antibodies directed against human cell surface antigens was performed accord-
ing to the manufacturers methods (Bectin-Dickinson, Ortho Diagnostics). Cell 
suspensions were washed twice with PBS-5% FCS and adjusted to a concentration 
of lOx 10 6/mJ. 100111 of this suspension ( 1 x 10 6 cells) was added to RTU 
tubes (Becton-Dickinson) or round-bottomed microtitre plates containing the 
requisite amount of McAb (Appendix 1) and PBS-5% FCS to a final volume of 
200111.· The cell and McAb mixture was incubated on ice for 30 mins with the 
occasional gentle mixing. The tubes/plates were centrifuged for 10 mins at 
400g, at 4°C, and the supernatants were carefully aspirated from the cell 
pellet. Cells were resuspended and washed twice with PBS-5% FCS to remove 
excess unbound McAb. The second layer antibody was affinity purified 
Fluorescein isothiocyanate {FITC}-conjugated goat anti-mouse IgG (Tago). The 
McAb labelled cell pellet was gently resuspended by tapping the tube/plate, 
100111 of the second layer antibody was added (511g/1 x 106 cells) and the cells 
were incubated for 30 mins on ice. The stained cells were washed twice with 
cold PBS-5% FCS and resuspended in 100111 of the same buffer for flow cyto-
metr ic analysis. 
Counting of B cells also used an indirect immunofluorescence technique. 
The first layer antibody was affinity purified goat anti-human Ig (3.7I1g/1 x 10 6 
cells) (Tago), 30 mins on ice. After 2 washes with PBS-5% FCS, bound antibody 
was detected with FIlC-conjugated swine anti-goat Ig (5119/1 x 10 6 cells) 
(Tago). After washing, labelled cells were resuspended in 100111 PBS-5% FCS for 
analysis. 
Controls of cells stained with the second layer antibody alone were used in 
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TABLE 2.1 
MONOCLONAL ANTIBODIES TO HUMAN CELL SURFACE RECEPTORS 
Antigen 
Name 
leu-l * 
b. leu-2a/OKT8 
leu-3a 
leu-3a + 3b/ 
OKT4 
leu-4/0KO 
leu-5 
HlA-DR/FMC4 
B2M 
HTAI 
W6/32 
TG-l 
2D-l 
3A-l 
MW (Kdal) 
67 
32 & 43 
55 
55 
62 
20 - 30 
50 
28 & 34 
12 
45 
28 & 34 
40 
Cellu lar distribut ion 
+ 95% thymocytes, > 85% E 
T cells, 72% normal PBl 
20-40% peripheral T cells, 
60-85% thymocytes 
35-55% PBls, 80-95% 
thymocytes 
" 
+ 68-82% PBls, 80-85% E 
T cells, 65-85% thymocytes 
+ 78-88% PBls, 95-100% E 
T cells, 96-99% thymocytes 
7-15% PBls 
All human cells 
85% thymocytes 
65% T cells 
Population 
defined 
Mature T cells 
T suppressor/ 
cytotoxic 
T helper/inducer 
" 
Pan T cell 
E rosette 
B cells, 
activated T cells 
B.microglobulin 
Thymocyte 
HlA-ABC framework 
Granulocyte 
Common leucocyte 
Activated T cell 
References 
1,2 
2,3,4 
2,3,5 
6,7,8 
2,8 
9, 10 
11, 12 
11 
13 
14 
15 
15 
16 
OKT6 70% thymocytes Cortical thymocyte 17 
OKMI 78% adherent mononuclear Monocyte 18 
cells, 18% null cells 
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all experiments. 
Cell analysis was on a F ACS IV (Becton-Dickinson, Sunnyvale, CA) with a 
2 watt argon laser (Spectra Physics model 164-06) tuned at 488nm with 180mV 
power. 
2.3.5 Sterile sorting of hybrids 
At 14 days post fusion, the plates containing CEM-6TGR X Con A 
PBL putative hybrids were assessed microscopically for evidence of cell growth. 
Two wells from fusion experiment 1 and one well from fusion experiment 2 were 
selected because of viable cell growth and these individual wells were expanded 
into tissue culture flasks (Nunc) for 1 week in RPMI, HAT, 20% FCS. The 
expanded cultures were then stained with the OKT3 McAb (Ortho Diagnostics, 
pan T cell McAb) and the OKT3+ staining population was sterile-sorted directly 
into a 2054 tube (B-D) containing 1 ml RPMI. Dual parameter gated analysis 
was used in setting up narrow selection windows to exclude non-viable and 
OKT3- hybrids. These sorted cells were cultured and conditioned through HT 
(no aminopterin) supplemented media into RPMI, 15% FCS over the next 12 days. 
Four hybrid lines were established in this manner. TT -1 and TT -2 were 
established by separate sterile sorts of cells from fusion experiment 1, TT-3 
resulted from a second OKT3+ sort of TT -2 and TT -4 was established from 
fusion experiment 2. These lines were maintained in culture in RPMI, 15% 
FCS and samples were frozen at regular intervals and stored in liquid nitrogen. 
The surface phenotype of the lines was assessed from 10-140 days post fusion. 
2.4 CHROMOSOMAL ANALYSIS 
Chromosomal analysis of parental and hybrid cells used standard procedures. 
Exponentially growing cell cultures were treated with colchicine (0.2\lg/ml) for 
1-2 hrs, centrifuged and washed with 0.075 M KCI. Cells were fixed with 
methanol: acetic acid (3:1, v/v) and metaphase slides were prepared by airdrying . 
. Banding was performed using trypsin. 
2.5 FUNCTIONAL HYPOXANTHINE GUANINE PHOSPHORIBOSYL 
TRANSFERASE (HGPRT) ACTIVITY 
The ability of parental and hybrid cells to incorporate preformed hypox-
anthine via the salvage enzyme HGPRT, was assessed directly by utilising 
3H-Hypoxanthine. The method used was based on that of Morley et al (1983). 
Twelve replicates of 5 x 10'+ cells per well were grown in 96 well 
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round-bottomed microtitre plates for 48 hrs in a total volume of 200].11. Six 
replicates were pulsed with 2.0].1Ci [3H (G)]-Hypoxanthine (NEM, spec act 9.1 
Ci/mmol) and the other six replicates with 2.0].1Ci [6- 3H]- Thymidine (Amersham, 
spec act 5Ci/mmol) for 21 hrs. The cells were then harvested onto glass fibre 
filters using an automated cell harvester (Skatron, Norway), dried at 60°C for 
at least 1 hr and counted by liquid scintillation (Appendix 2). 
2.6 FUNCTIONAL ASSAYS 
2.6.1 Introduction 
Functional assays were developed prior to the construction of 
human T cell hybrids to enable the screening of hybr id-derived supernatants for 
possible effects on in vitro T and B cell responses. Two B cell antibody systems 
were developed and validated. The first, utilised a relatively simple radioimmuno-
assay to measure total and specific antibody production to the hapten-linked 
proteins dinitrophenyl-bovine serum albumin (DNP-BSA) and dinitrophenyl-keyhole 
limpet hemocyanin (DNP-KLH) in the presence of the polyclonal activator poke-
weed mitogen (PWM). A number of methods were exploited to circumvent the 
need for PWM to trigger B cell differentiation and immunoglobulin secretion. 
This assay system was used to screen for hybrid-derived lymphokine effects on 
the polyclonal activation of normal human B cells in vitro. A second antibody 
assay, a hapten-specific system, was developed which enabled the generation 
and quantitation of hapten-specific antibody responses in the absence of poly-
clonal activators or other exogenous stimuli. This system will be of use in the 
future for the development and assaying of hybrids secreting lymphokines with 
specificity for hapten-carrier conjugates. The effects of hybrid-derived 
lymphokines on T cell responses were measured using a short term phytohem-
agglutinin (PRA)-stimulated T cell proliferation assay. 
2.6.2 Human antibody assay (pokeweed mitogen-dependent) 
2.6.2 (a) Antibody tracers 
Direct binding assays were performed to quantitate total 
and specific IgG or IgM antibody production using 1251 labelled goat anti-
human IgG or IgM as the radioact ive tracer. 
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The chloramine T method of Hunter (1974) was used to radioiodinate the 
tracer antibody to a relatively high specific activity. 
All tracer iodinations were performed in a modified fume hood using 
biogamma (Ansell) gloves. Standard "hot laboratory" procedures were strictly 
applied. 
5JJI (0.5mCi) Na 1251 (Amersham, IMS.30, pH 7-11, 100mCi/ml) was mixed 
with 20JJI 0.5M Na2 PO .. buffer pH 7.4 and cooled on ice. 50JJI (50JJg) affinity 
purified goat anti-human IgG or IgM (T ago) was then added and cooled on ice 
for 30 secs. 20JJI chloramine T (Sigma) (l mg/ml) was added, to oxidase the 
Na 125I, and mixed for 60 secs on ice. 20JJI sodium metabisulphite (2mg/ml), to 
reduce any unreacted 125} back to 12 5iodide, was added and stirred on ice for 
120 secs. 50JJI potassium iodide (lOmg/ml) was added to stabilise the labelled· 
1251. The iodinated protein mixture was applied to a Sephadex G50 (Pharmacia 
Fine Chemicals) column (1.5 x 12cm) and eluted with PBS pH 7.4 at a flow rate 
of 0.5ml/min to separate the free and bound tracer. 0.5ml fractions were 
collected and 5JJI aliquots were gamma counted (Beckman Biogamma) to 
determine the positions of the labelled antibody and free tracer. A pool of 
the most active fractions was made and the specific activity calculated from 
the d.p.m and protein concentration. 
2.6.2 (b) Antigens 
DNP-BSA (Calbiochem) 34.6 DNP residues/BSA residue, stock 
solution prepared in deionised H2 0. DNP-KLH (Calbiochem) 625 moles DNP/ 
mole hemocyanin; based on a MW of 2 x 10 6 daltons, stock solution prepared 
in ethanol. PWM (Sigma) stock solution prepared in RPMI. Antigen and mitogen 
stocks were filter sterilised using a 0.2JJm disposable filter (Acrodisc, Gelman) 
and frozen at -20°C until used. 
2.6.2 (c) Culture conditions 
Optimal cell and antigen concentrations were determined for 
both DNP-BSA and DNP-KLH in the presence of PWM (lJJg/ml) (mitogenic dose). 
2ml cultures were performed in supplemented RPMI 1640, 10% FCS in 24 well 
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macro-plates (Nunc) for 6-7 days at 37°C in a 5%CO z atmosphere. At the end 
of this period cell free supernatants were collected by centrifugation, assayed 
immediately for total IgG/lgM or anti-DNP IgG/IgM antibodies, or stored at 
-20°C for subsequent antibody determinations. 
2.6.2 (d) Antigen concentration 
Freshly isolated PBLs (1 x 10 6/ml) were cultured with 
varying concentrations of DNP-BSA or DNP-KLH and PWM (I \lg/ml). The 
antigen concentrations were 0.0 I, 0.1, 1.0 and 1O.0\lg/ml. Controls utilised 
cells cultured in the absence of antigen to determine the level of specific 
antibody production in response to PWM stimulation alone. 
2.6.2 (e) Cell concentration 
Varying numbers of PBLs (0.25, 0.5, 1.0, 1.5, 2.0, 3.0, 
4.0 and 5.0 x 106 ) were cultured with DNP-BSA (0.1 \lg/ml) and PW M (1 \lg/ml) .. 
Controls utilised varying PBL numbers cultured with PWM or PBLs alone. 
2.6.2 (f) Alternatives to polyclonal activation with pokeweed 
mitogen 
Cui tures were performed using hydrocortisone (l 0- 5 M) 
(Lobo & Spencer, 1979) to inhibit T suppressors without affecting the T helpers, 
or IL-2 (1: 10) to expand the antigen-activated T cells {Aarden et aI, 1979}. 
PBLs ( 1 x 106 /ml) were cultured with either DNP-KLH (0.1 \lg/ml) + 
IL-2 (1: 10) (BRL), Hydrocortisone (10- 5 M) + DNP-KLH (0.1 \lg/ml) or DNP-KLH 
alone. All cultures were performed in the presence and absence of PWM 
(1 \lg/ml). Controls utilised PBLs cultured with and without PWM. 
2.6.2 (g) Radioimmunoassay 
A solid phase RIA, based on the method of Nonaka et 01 
(1981) was developed. 96 well round-bottomed flexible polyvinyl plates (Cooke) 
were coated with goat anti-human IgG or IgM (2\lg/ml), to measure total IgG or 
IgM antibodies, or DNP-carrier (lOO\lg/ml) to measure DNP-specific antibodies, 
in PBS pH 7.4 at 4°C overnight. The plates were washed with PBS and non-
specific binding sites were blocked with 3% BSA, 0.2% azide in PBS for 30 mins 
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at raom temperature. After extensive washing, 50)11 samples (triplicate 
determinations) were incubated at 4°C for 4 hrs. After washing, 50)11 125 1 
goat anti-human IgG or IgM (spec act 8-12 )1Ci/)1g at time of preparation, 
diluted to give approximately 8 x 10 4 cpm/50)1l) in 3% BSA-PBS was added 
and incubated at 4°C overnight. The wells were aspirated and extensively 
washed with PBS. Individual wells were cut out and the bound radioactivity 
was counted in a gamma counter (Beckman Biogamma). Results of triplicate 
determinations were expressed as cpm-background ± SD of sample means. 
Background binding in each assay was assessed using FCS at the same 
concentration as the samples, and was generally 100-200 cpm. Using this RIA 
one was able to measure total or DNP-specific antibody production. 
2.6.2 (h) Validation of the radioimmunoassay 
Three methods were used to validate the RIA. 
1) culture supernatants from a PBL culture (1 x 10 6 /ml) 
with DNP-KLH (O.l)1g/ml), PWM (l)1g/ml) were 
serially diluted with RPMI, 10% FCS and assayed to 
to ensure a "classical" dose response curve for total 
IgG and IgM ant ibodies was produced. 
2) Supernatants from a PBL (1 x 10 6 /ml), IL-2 (1:10) 
DNP-KLH (O.l)1g/ml), PWM (l)1g/ml) culture were 
titrated with increasing amounts of ovalbumin, DNP-
BSA and KLH. The amount of free antibody left in 
the supernatant was determined after an overnight 
incubation at 4°C and centrifugation to remove 
antigen-antibody complexes. 
3) An IgG standard curve was constructed using a 
serum standard quantitated by the Biochem. Dept., 
Christchurch Hospital, in the range of 0.1 ng-1 OO)1g/mI. 
A standard curve of IgG concentration versus 
125 1 Get Hu IgG cpm bound was constructed from this. 
2.6.2 (i) Effect of hybrid-derived supernatants on a PWM-induced 
polyclonal antibody response 
Cell free supernatants derived from the hybrid lines, 
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TT -1 to TT -4, were screened for pOssible regulatory effects on the polyclonal 
antibody response of normal PBLs stimulated with PWM. Hybrids were tested 
for both constitutive and induced (ConA-treated) production of lymphokines. 
Preliminary experiments indicated that supernatants derived from the 4 
lines had a suppressive effect on the generation of an in vitro PWM-induced 
polyclonal antibody response. One line (TT -4), had the most potent effect and 
this was chosen for more detailed study. 
i) Constitutive lymphokine production 
Cells from the TT -4 line were grown at three densities (0.5, 
1.0, 5.0 x 10 6 /ml) for 5 days and cell free supernatants derived from these 
hybrid cells were added at the commencement of a PWM-induced antibody 
culture at final dilutions of 1 :2, 1: 1 0 and 1 :50. The assay was that described 
above and the culture was for 7 days. The cell free supernatants from this 
PWM culture were then assayed for total IgG antibodies by the solid phase 
RIA described in Section 2.6.2 (g). 
ii) Hybrid induction 
TT -4 cells were seeded at two densities (0.5 and 1.0 x 10 6 /ml) 
and each cell culture was stimulated for 48 hrs with 1,5 and lOjlg/ml ConA. At 
the end of this period, cell free supernatants were harvested and added at the 
commencement of a PWM-induced antibody assay at a final dilution of 1 :2. 
After 7 days the cell free supernatants from this PWM culture were assayed 
,for total IgG antibodies as described. 
2.6.3 Human hapten-specific antibody responses 
2.6.3 (a) Introduction 
A microculture and RIA was developed which was capable 
of generating and detecting very small levels of human anti-hapten antibody 
produced in a primary response without the addition of high concentrations of 
serum, mitogens or the prior immunisation of the donor with antigen. This 
assay was optimised for cell density end antigen concentration. In addition, the 
kinetics, T cell dependence and specificity of the anti-hapten response were 
inves tigated. 
2.6.3 (b) Antigens 
DNP-BSA and DNP-KLH hapten-carrier conjugates were 
the same as described in Section 2.6.2 (b). 
2.6.3 (c) T and B cell purifications 
i) Preparat ion of ant ibody coated plates 
Petri plates (Falcon, 100mm diameter) were incubated 
overnight at 4°C with 5ml rabbit anti-human IgG/Fab (Behring) at 232].1g/ml in 
Tris buffered saline pH 7.4. Coated dishes were washed 4 times with PBS. 
ii) 
The panning technique of Mage et al (1977) was used. 
PBL suspensions (5 x 10 7 15ml), were added to the coated plates and incubated 
for 2 hrs at room temperature. Half-way through the incubation period, the non-
adherent cells were resuspended by manually swirling the plate and allowing to 
resettle. Non-adherent cells were then removed by gentle decantation and the 
plates were gently washed 5 times with 5-10ml PBS-1 % FCS. Adherent cells 
were removed by vigorously pipetting with 10-15ml PBS-1 % FCS with a pasteur 
pipette followed by scraping with a rubber policeman. 
The non-adherent cells were further depleted of contaminating T cells by 
complement-dependent lysis using a monoclonal antibody and complement. 
Adherent cells were incubated with OKT3 (5].1g/1 x 10 6 cells) in a volume of 
200].11 in deficient RPMI 1640 (Irvine Scientific), 5% FCS for 30 min on ice, 
then washed twice with deficient RPMI. The cell pellet was incubated with 
rabbit complement (GIBCO) (100].11/ 1 x 10 6 cells), at 37°C for 1 hr and washed 
twice with RPMI. 
iii) T and B cell quantitation 
T cells were quantitated in the final adherent and 
non-adherent populations by indirect staining with the Leu-1 McAb as described 
in Section 2.3.4. 8 cell quantitation utilised an immunofluorescence technique 
as described in the same section and cell analysis was on a FACS IV. 
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2.6.3 (d) Culture conditions 
The optimal antigen concentration, cell density and 
kinetics for the generation of anti-hapten antibodies were determined. Human 
PBls or purified B or T cell populations were cultured for 5-7 days with either 
DNP-BSA, DNP-KlH or in the absence of antigen in a total volume of 200111 in 
96 well flat-bottomed microtitre plates. The culture medium was supplemented 
RPMI 1640,5 x lO-sM 2-mercaptoethanol, 10% FCS. At the end of the culture 
period the cells were washed 3 times with fresh medium and resuspended in 
medium without antigen. After a further 4 days in culture, the supernatants 
were immediately assayed or stored at -20°C. 
2.6.3 (e) Antigen concentration 
1 x 10 6 cells/200111 were cultured in the range of 0.1-
50l1g of antigen as described and the level of anti-hapten antibodies was then 
determined. 
2.6.3 (f) Cell concentration 
Varying numbers of human PBls ( 0.5-20.0 x 10 5 ) were 
cultured with DNP-BSA, DNP-KlH (l.Opg/ml) or without antigen for 5 days. 
After washing and a further 4 days in culture, supernatants were assayed for 
the presence of anti-hapten antibodies. 
2.6.3 (g) Kinetics of anti-hapten response 
The kinetics of the anti-hapten response was studied by 
setting up cell cultures of PBl (l x 10 6 ) with DNP-BSA, DNP-KlH (1.0fl9) or 
without antigen. At the times indicated (Figure 3.18) the cells were washed 
3 times with fresh medium and cultured for a further 4 days in the absence of 
antigen. Culture supernatants were harvested and stored at 20°C until assayed 
as one batch. 
2.6.3 (h) T cell dependence of anti-hapten response 
To determine if this antigen-driven culture system was 
T cell dependent, varying numbers of purified T cells were mixed with a 
constant number of B cells ( 5 x 10 5 ) and cultured with DNP-BSA (0.1fl9) in the 
microcul ture. 
2.6.3 (i) Hapten-specific radioimmunoassay 
The assay procedure was essentially that described 
(Morimoto et aI, 1981). 96 well round-bottomed flexible polyvinyl plates 
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were coated with DNP-BSA (1 mg/ml in PBS) at 4°C overnight. After blocking 
and washing as previously described, 50111 aliquots (triplicate determinations) of 
culture supernatants were assayed. Again the tracer was affinity purified 
(ll chain specific) 125 1 goat anti-human IgM (8 x 10 it cpm) in 1 % BSA-PBS. 
After overnight incubation and washing individual wells were cut out and gamma 
counted. Background binding was determined using 10% FCS with the results 
being expressed as cpm - background ± SD of sample means. 
2.6.3 (j) Specificity of radioimmunoassay 
The specificity of the RIA was confirmed by titrating 
DNP-BSA or ovalbumin into anti-hapten antibody culture supernatants as 
described in Section 2.6.2 (h). 
2.6.4 T cell proliferation assay 
TT -4 supernatants were added at the commencement of a T cell 
proliferative response assay to determine if the hybrid-derived supernatants 
contained lymphokines which could in some way modify this response. 
Purified PBls were stimulated with 1 % PHA (M form) (GIBCO) for 48 hrs, 
washed twice to remove residual lectin, and plated in a 96 well round-bottomed 
microtitre plates (5 x 10 it/well). Cells were cultured in RPMI, 15% FCS with 
partially purified human Il-2 at a final dilution of 1: 10. Dilutions of hybrid 
supernatants were titrated in with the cells and Il-2. Cells were cultured for 
a further 48 hrs followed by a 16 hr pulse with 3H_ Thymidine (2.0llCi/ well). 
Cells were harvested onto glass fibre filters, dried and counted by liquid 
scintillation. 
2.7 PRELIMINARY BIOCHEMICAL STUDIES OF HYBRID-DERIVED FACTORS 
2.7.1 Gel filtration chromatography 
Concentrated TT -4 supernatant was chromatographed on a 
Sephacryl 5-200 column which had been calibrated using protein standards of 
known molecular weights. 
2.7.1 (a) calibration 
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A LKB K26 column (90 x 2.6cm) was packed with 
Sephacryl 5-200 (Pharmacia Fine Chemicals). The flow rate was 15ml/hr and 
the column was eluted with PBS pH 7.4. A 5ml cocktail of the following 
protein standards was pumped onto the equilibrated column and eluted at 15ml/ 
hr. The protein standards were: 1 mg each of catalase (210,000), 
phosphorylase b (97,000), BSA (67,000), ovalbumin (43,000) and myoglobin 
(16,700). Blue dextran was added to the cocktail to estimate the void volume 
(Vo>2.5 x 10 5 daltons). A standard curve of Kav versus log MW was constructed 
from the elution volumes of the protein standards and blue dextran. 
2.7.1 (b) TT -4 chromatography 
90ml of TT -4 supernatant was concentrated to 6.5ml by 
Amicon ultrafiltration over a P5AC-103 MW membrane (Millipore Corporation). 
5ml of concentrated supernatant was chromatographed on the calibrated S-200 
column at 15ml/hr with 5ml fractions being collected. Tubes corresponding to 
various M W ranges were pooled, concentrated to 3ml over a PSAC-10 3 membrane, 
filter sterilised and assayed in the short-term T cell proliferation assay. 
2.7.2 Physicochemical characterisation 
Certain physicochemical characteristics of the TT -4 supernatants 
were investigated. Supernatants were dialysed against 0.2M glycine buffer 
pH 2.0 or 0.2M Tris buffer pH 9.0 for 24 hrs at 4°C. Supernatants were also 
treated with 50mM dithiothreitol (OTT) (Research Organics). These treated 
supernatants were dialysed extensively against RPMI and filter sterilised before 
being tested in the short-term T cell proliferation assay. Supernatants were 
also cocultured with the monosaccharides L-rhamnose, a-methyl mannoside, 
L-fucose and N-acetyl glucosamine (Sigma) (all 50mM) in the T cell 
proliferation assay. Controls for all samples utilised RPMI, 15% FCS treated 
in an identical manner to the TT -4 supernatants. 
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CHAPTER 3. 
RESULTS 
3.1 INTRODUCTION 
aim of this work was to develop somatic cell hybridisation techniques 
as a means of immortalising normal T cell function. The basic assumption made 
with cell hybridisation studies such as these is that the secretory activity of the 
normal lectin-activated T cell will be immortalised on the continuously prolifer-
ating background of the parental leukemic cell. 
3.2 CHARACTERISTICS OF PARENTAL CELL LINES 
This section of the thesis describes a number of growth and phenotypic 
characteristics of the parental leukemic and derived T cell hybrid lines. 
Sections 3.2 3.4 present the results of these studies. 
3.2.1 Derivation of drug-resistant parental T cells 
A 6-thioguanine-resistant (6TGR) leukemic T cell line was established 
as the parental line for the construction of human T cell hybrids. 
Table 3.1 describes the efficiency of recovery of CCRF-CEM cells follow-
ing an initial mutagenesis with varying concentrations of EMS. 38-56% (50-1).1g/ 
ml EMS respectively) of the mutagenised cells were still viable after 24 hrs 
compared to 85% in the non-mutagenised controls. 
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TABLE 3.1 
EMS MUTAGENESIS OF CCRF-CEM LINE 
EMS concentration (~g/ml) 0 1 5 10 50 
Viable cells seeded (x 10-6/ml ) 1.0 1.0 1.0 1.0 1.0 
Viable cells recovered 0.85 0.56 0.53 0.42 0.38 
-6 
after 24 hrs (x 10 Iml) 
EFFiciency of recovery (%) 85 56 53 42 38 
Exponentially growing CCRF-CEM cells were with varying concentrations of EMS 
(0-50~g/ml). The efFiciency of recovery of the EMS-treated cells aFter 24 hrs is shown. 
Table 3.2 (a) describes the recovery of cells following an increase in the. 
6TG concentration from O.1~g/ml (5.5 x 1O- 7 M)to 1.0~g/ml (5.5 x 10- 6 M). 
Recoveries of 54-76% were achieved after 5 days. 
TABLE 3.2 (a) 
6TG SELECTION OF EMS-TREATED CCRF-CEM LINE 
EMS concentration (~g/ml) 1 5 10 50 
6TG concentration (~g/ml) 1.0 1.0 1.0 1.0 
Viable cells seeded (x 1O-6 /ml) 0.5 0.5 0.5 0.5 
Viable cells recovered 
after 5 (x 10-6 /m!) 0.27 0.38 0.30 0.28 
EFficiency of recovery (%) 54 76 60 56 
EMS-treated CCRF-CEM cells were cultured for 7 days in RPM!, 15% rcs supplemented with 
O.l~g/ml 6TG. Cells exhibiting growth were expanded into tissue culture flasks at the 
viable cell concentrations shown and treated with 1.0~g/ml 6TG. The of 
recovery after 5 days is shown. 
These cultures were then reseeded at the densities indicated in Table 
3.2 (b) and the 6TG concentration was increased to 1.36).lg/ml (7.5 x lO-6M). 
Recoveries of 48-79% were achieved after 3 days. 
TABLE 3.2 (b) 
6TG SELECTION OF EMS-TREATED CCRF-CEM LINE 
EMS concentration ().lg/ml) 1 1 5 5 10 10 50 
6TG concentration ().lg/ml) 1.0 1.36 1.0 1.36 1.0 1.36 1.0 
Viable cells seeded 
-6 (x 10 /ml) 0.85 0.85 0.95 0.95 0.60 0.60 0.28 
Viable cells recovered 
-6 
after 3 days ( x 10 /ml) 0.51 0.41 0.50 0.48 0.44 0.43 0.22 
Efficiency of recovery (%) 60 48 52 51 73 72 79 
61. 
50 
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EMS-treated cells were further treated with increasing concentrations of 6TG. Cells were 
seeded at the viable cell concentrations shown and treated with 1.0 and 1.36).lg/ml 6TG. 
The efficiency of recovery after 3 days is shown. 
The EMS-mutagenised CCRF-CEM line which exhibited the best growth 
characteristics (lO).lg/ml EMS) was selected with increasing concentrations of 
6TG. Table 3.2 (c) describes the viable cell recovery when this line was 
treated with 1-5.44).lg/ml 6TG ( 5.5 x 10- 6 - 3.0 x 10- 5 M). 
A line resistant to 5.44).lg/ml 6TG continued to grow well in culture, and 
was further selected with 6TG at 18).lg/ml (1.0 x 10-4M). This line, CEM-6TG R, 
was maintained in 6TG-supplemented tissue culture medium, 15% FCS and was 
used as the drug-resistant parental hybrid line. 
TABLE 3.2 (c) 
6TG SELECTION OF EMS-TREATED CCRF-CEM LINE 
EMS concentration (fig/ml) 10 10 10 
6TG concentration (fig/ml) 1.0 1.36 5.44 
Viable cells seeded 
-6 (x 10 /ml) 0.34 0.33 O.lB 
Viable cells recovered 
-6 
after 4 days (x 10 /ml) 0.40 0.40 0.36 
Efficiency of recovery (%) lIB 121 200 
A line of EMS-mutagenised CeRF -CEM cells (lOfig/rnl EMS), resistant to 1. Ofig/ml 6 TG, 
was seeded at the viable cell concentrations shown and selected with 1.0, 1.36 and 
5.44fi9/ml 6TG. The efficiency of recovery after 4 days is shown. A line resistant 
to 5.44fig/ml 6TG was selected with 18fig/ml 6TG and maintained as the CEM-6TGR 
parental hybrid line. 
3.2.2 Growth rates 
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Figure 3.1 describes the growth characteristics for the CCRF-CEM, 
CEM-6TGR and CEM-AG R lines. Estimates of the doubling times of these 
lines were: 
1) CCRF-CEM 
2) CEM-6TGR 
3) CEM-AGR 
26 hr, 
30 hr, 
28 hr. 
Inhibition of growth was observed after 120 hrs in culture (2 x 10 5 /ml) for the 
CCRF-CEM line and 140 hrs (2 x 10 6 Iml) for the CEM-Acf line. 
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FIGURE 3.1 
GROWTH RATES OF PARENTAL CELL LINES 
Graph of log viable cell number/ml versus hours in culture. Estimates of doubling times 
for the parental lines were made while the cells were in exponential growth (48-96 hrs 
in culture). 
_ CEM - AGR 
~ CCRF - CEM 
~ CEM - 6TGR 
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3.2.3 Terminal deoxynucleotidyl transferase staining 
R Both CCRF-CEM and CEM-6TG were TdT negative as assessed by 
the fluorescent antibody staining technique ibed. Mr M. Southern, Dept. 
Pathology, Christchurch Clinical School of Medicine, kindly performed the TdT 
staining. 
3.2.4 HA T sensitivity 
HAT sensitivity experiments were performed by culturing CEM-
6TGR cells directly in HAT-supplemented tissue culture medium. Every two 
days the cells were counted and recultured at a viable density of 5 x lOs/ml. 
Figure 3.2 indicates that no viable cells were present after 7 days in culture. 
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FIGURE 3.2 
HAT SENSITIVITY OF CEM-6TGR LINE 
2 4 6 
Days in culture 
8 
CEM-6TGR cells were seeded in HAT medium at 5 x 10S/ml (Day 0). 2 days cells were 
counted and reseeded at a viable density of 5 x I05/ml in fresh HAT medium. The graph 
shows the number of viable cells/ml at the times indicated. 
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3.3 HUMAN T CEll HYBRIDS CRITERIA FOR HYBRIDISA nON 
To confirm that true human T cell hybrids had been produced from the drug 
and phenotypic selection programme adopted, three independent techniques were 
used as indicators of hybridisation. The three criteria investigated were: 
1. 
2. 
3. 
cell surface phenotype 
acquisition of functional HGPRT activity 
chromosomal analysis 
3.3.1 Surface phenotype of parental and hybrid cells 
Section 3.3.1 
Section 3.3.2 
Sect ion 3.3.3 
Cell surface phenotype studies were performed on both the parental 
and hybrid cells to determine whether particular cell surface receptors, absent 
on the parental tumor line but present on normal T cells, were subsequently 
expressed on the HAT - selected putative hybrid cells. 
Indirect immunofluorescence staining indicated that the 5 day ConA-
activated PBls contained greater than 85% leu-4 positive (T cells) and less than 
7% surface membrane immunoglobulin (SmIg) positive cells (8 cells). FACS 
profiles for the T and B cell staining are in Figure 3.3. 
CEM-6TG R and CEM-AGR cells were screened with a range of monoclonal 
antibodies to the human cell surface receptors described in Table 2.1. 
FIGURE 3.3 
FACS PROFILE OF 5 DAY ConA-ACTIVATED PBLs 
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A. Histogram of light scatter (horizontal axis) versus relative cell number for the 
5 day ConA-activated PBLs. 
B. Composite histogram of log fluorescence (horizontal axis) versus relative cell 
number for the 5 day ConA-activated PBLs stained with Smlg (B cells) and Leu-4 
(T cells). Percentages of cells positive staining were calculated to the right 
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of the curser line indicated. The cursor position was determined after comparison 
with unstained control cells. 
Figure 3.4 (a) shows the scatter and fluorescence profiles for the unstained 
CEM-6TGR line. Figure 3.4 (b) shows the fluorescence profiles for the CEM-
6TGR line stained with the indicated McAbs. 
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FIGURE 3.4 
FACS PROFILE OF UNLABELLED CEM-6TGR LINE 
100 2000 100 
Channel number Channel number 
Histogram of scatter versus relative cell number for CEM-6TGR cells. 
R Histogram of log fluorescence versus relative cell number for CEM-6TG cells. 
R The channel number of the peak indicates that unlabelled CEM-6TG cells do not 
exhibit appreciable levels of autofluorescence. 
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FIGURE 3.4 
FACS PROFILE OF McAb - LABELLED CEM-6TG R LINE 
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Histogram of log fluorescence versus relative cell number for CEM-6TGR cells labelled 
with the indicated McAbs. Gated analysis indicated that > 95% of cells were Leu-l 
and Leu-3a positive. < 5% of cells were OKT3 positive. 
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Table 3.3 presents the cell surface phenotype data for the CEM-6TGR and 
CEM-AGR lines. Interestingly, neither expressed -the receptor recognised by the 
OKT3 or Leu-4 McAbs. As normal T cells express this receptor, its presence 
(following fusion and HAT selection) was used to set sorting windows on the FACS 
to facilitate sterile sorting of the OKT3 receptor positive hybrid cell population. 
Both lines. failed to express the E rosette receptor recognised by the Leu-5 
McAb. This marker is usually expressed on 95-100% human T cells. 
TABLE 3.3 
CELL SURFACE PHEI\JOTYPE OF CEM-6TGR & CEM-AGR LINES 
McAb 
Leu-l 
Leu-2a I OKT8 
Leu-3a 
Leu-3a I OKT4 
Leu-4 I OKT3 
Leu-5 
HLA-OR I FMC4 
B2M 
HTAI 
w6/32 
TG-l 
20-1 
3A-l 
OKT6 
OKMI 
PNA 
NT 
+ staining 
- staining 
± weak staining 
Antigen Recognised 
Mature T cell 
Ts/c 
Th/i 
Th/i 
T cell 
E rosette 
HLA-OR framework 
B2 microglobulin 
Human thymocyte 
HLA-ABC framework 
Granulocyte 
Common leucocyte 
Activated T cell 
Cortical thymocyte 
Monocyte 
Peanut agglutinin 
not tested 
> 95% cells positive 
< 5% cells positive 
5-15% cells positive 
receptor 
CEM-6TGR . CEM-AGR 
+ + 
± ± 
+ + 
+ + 
+ + 
+ NT 
+ + 
± ± 
NT 
NT 
NT + 
Indirect immunofluorescence staining was performed on the CEM-6TGR and CEM-AGR lines 
using the monoclonal antibodies described in the table. The method used was that 
described in Section 2.3.4 and cell analysis was on a FACS IV. 
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IV. 
Simplified membrane phenotypes of the T cell hybr id lines, TT -1 to TT -4, 
are shown in Table 3.4. This table shows that 2.6-3.0% of the putative hybrid 
cells were expressing the OKT3 marker 10 days post fusion. The four lines 
demonstrated relatively stable OKT3+ percentages or an enrichment of the 
OKT3+ cells when stained at 76-90 days post fusion. By 140 days post fusion, 
a significant loss of expression of the OKT3 marker had occurred in all the 
four lines (0-6.0% OKT3+). 
TABLE 3.4 
OKT3 McAb STAINING OF HUMAN T CELL HYBRID LINES 
Days post fusion 
TT -1 
10 2.6 
14 27 
26 NT 
56 NT 
76 26 
90 46 
140 0 
A 
NT 
% of cells expressing OKT3 marker 
Not tested 
Hybr id line A 
TT-2 TT-3 
2.6 2.6 
27 28 
NT NT 
27 28 
40 20 
66 48 
2 6 
TT-4 
3.0 
27 
37 
40 
66 
27 
5 
Hybrid cells from the 4 lines were stained with the OKT3 McAb from 10-140 days post 
fusion using the indirect immunofluorescence staining technique. Cell analysis was 
on a FACS IV. 
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Table 3.5 shows that at 90 days post fusion, all four lines exhibited dual 
expression of both the Leu-2a (T suppressor/cytotoxic) and Leu-3a (T helper/ 
inducer) markers. Interestingly, the levels of expression of either marker were 
comparable within each of the hybrid lines, but a large variation in staining 
was evident between the lines (31-80% Leu-2a +, 33-72 % Leu-3ci+). 
TABLE 3.5 
SIMPLIFIED CELL SURFACE PHENOTYPE OF HUMAN T CELL HYBRID LINES 
McAb 
Leu-l 
Leu-2a 
Leu-3a 
Leu-l 
Leu-2a: 
Leu-3a: 
TT -1 
95 
44 
47 
TT-2 
100 
72 
72 
% of cells expressing the indicated markers 
mature T cell; 
T suppressor / cytotoxic; 
T helper / inducer. 
Hybr id line A 
TT-3 
100 
31 
33 
Hybrid cells were stained with the indicated McAbs at 90 days post fusion using the 
i~direct immunofluorescence staining technique. Cell analysis was on a FACS IV. 
TT-4 
100 
80 
72 
Figure 3.5 (a) describes the 3 dimensional display of the hybrid cells sorted 
to establish the OKT3+ TT -1 hybrid line. Figure 3.5 (b) is a line diagram 
indicating the scatter and fluorescence axes and the sorting windows used to 
isolate these hybrid cells. It is evident from Figs. 3.5 (a), (b) that the OKT3+ 
cells formed a discrete population on the scatter versus fluorescence profile. 
+ . 
This separation enabled the positive selection of the OKT3 hybrid cells as well 
as the exclusion of non-viable and OKT3- cells. 
THREE DIMENSIONAL DISPLAY OF OKT3 LABELLED HYBRID CELLS 
Three dimensional display of OKT3 labelled putative hybrid 
cells. Fig. 3.5 (b) describes the scatter and fluorescence 
axes and sorting windows used to isolate the OKT3+ hybrid 
cells identified in Fig. 3.5 (a). 
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FIGURE 3.5 (b) 
LINE DIAGRAM OF OKT3 LABELLED HYBRID CELLS 
FLUORESCENC E 
Line diagram indicating the scatter and fluorescence axes of the OKT3-stained hybrid 
+ 
cells described in figure 3.5 (a). The highlighted area describes the OKT3 hybrid 
cell population which was sterile sorted to establish the TT-l line. 
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3.3.2 Functional hypoxanthine guanine phosphoribosyl transferase 
(HGPRT) activity 
Resistance of the mutagenised CCRF-CEM line to 6TG suggested 
that it was deficient in HGPRT activity. 
To confirm that the CEM-6TGR line was in fact deficient in HGPRT 
activity, the ability of the line to incorporate preformed exogenous hypoxanthine 
was assessed with 3 H-Hypoxanthine. A ratio of 3H-Hypoxanthine to 3H_ Thymidine 
(3H-HX / 3H_ TdR) incorporation is shown in Table 3.6. This ratio relates cell 
growth rate to the ability to incorporate 3H-HX via the HGPRT enzyme. Table 
3.6 shows the uptake of 3H-HX, 3H_ TdR and the incorporation ratios for the 
control cells (lines 1-4) and hybrid lines (lines 5-8). 
A reduced 3H-HX / 3H_ TdR incorporation ratio for the CEM-6TGR fusion 
partner results from a significantly reduced ability to incorporate hypoxanthine 
compared to the non-mutagenised CEM line (0.006 vs. 0.49 respectively). T cell 
hybrid lines 1-4 had ratios approaching those of the non-mutagenised line; 
which suggested they received functional HGPRT activity from fusion with the 
ConA-activated PBLs. This is therefore evidence for hybrid formation. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
TABLE 3.6 
INCORPORA nON OF lH-HYPOXANTHINE & lH_ THYMIDINE BY 
PARENTAL CELLS AND T CELL HYBRID LINES 
Sample 
CEM (non mutagenised) 
CEM (mutagenised, hybrid 
parental cells) 
PBl 
PBl &: ConA (hybrid 
parental cells) 
TT-l 
TT -2 
TT -3 
TT-4 
lH-HX cpm 
(± SO) 
275638 ( 1.2) 
1498 (8.9) 
1367 (15.1) 
6397 (10.8) 
288432 (13.0) 
315360 ( 4.3) 
316379 ( 6.3) 
327937 ( 4.7) 
lH-TdR cpm 
( ± SO) 
557067 ( 7.7) 
249739 ( 9.4) 
299 (15.3) 
7878 (17.1) 
553229 (11.0) 
656673 8.3) 
693173 2.5) 
756222 ( 7.3) 
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ratio 
0.49 
0.006 
5.97 
0.81 
0.52 
0.48 
0.46 
0.44 
12 replicates (5 x 104 cells/200~1) were cultured for 48 hrs. 6 replicates were pulsed 
with 2.0~Ci 'H-HX and 6 with 2.0~Ci 'H-TdR for a FUrther 21 hrs. Cells were harvested 
onto glass Fibre Filters and counted by liquid scintillation. 
3.3.3 Chromosomal analysis 
The CEM-6TGR line had a mean chromosome number of 92 (range 
89-93); indicating tetraploidy. Analysis of TT -4 cells 120 days post fusion gave 
a range of chromosome number from 89-93 also. Some chromosome instability 
was evident in this line. 
Figure 3.6 describes a representative screen from the CCRF-CEM parental 
line. 
FIGURE 3.6 76. 
CHROMOSOME SCREEN OF CCRF-CEM LINE 
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FIGURE 3.7 
BANDING . PATTERN AND CHROMOSOME NUMBERING OF 
CCRF-CEM LINE 
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Figure 3.7 describes the banding pattern and chromosome numbering for 
the CCRF-CEM line. Two abnormal number nine chromosomes are present as 
well as one unidentified chromosome. 
The karyotyping was kindly performed by Dr P. Hollings, Cytogenetics 
Unit, Christchurch Hospital. 
3.4 ALTERNATIVE DRUG SELECTION SYSTEMS 
A direct comparison between the hypoxanthine, aminopterin, thymidine 
(HAT) and azaserine, hypoxanthine (AH) drug selection systems was made by 
culturing the putative hybrid cells from a fusion experiment in either medium 
and screening for visible cell growth at 30 days post fusion. 
Table 3.7 shows that of 144 wells seeded in either selective media, 14 
wells (9.7%) showed evidence of viable cells in the standard HAT media 
compared to 25 wells (17.4%) in the alternative AH media. 
TABLE 3.7 
NUMBERS OF T CELL HYBRIDS SELECTED IN EITHER HAT 
OR AH MEDIUM 
Number of wells seeded 
144 
144 
Medium 
HAT 
AH 
Number of wells 
with viable cells 
14 
25 
% wells positive 
9.7 
17.4 
Putative hybrids from a fusion experiment were selected in HAT or AH medium. Numbers 
of wells containing viable cells were quantitated by direct microscopic examination 
30 days post fusion. 
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3.5 FUNCTIONAL ASSAYS DEVELOPMENT AND VALIDATION 
Assay systems, capable of quantitating human PBL antibody responses were 
developed and validated. Hybrid-derived supernatants were screened in these 
assays to determine if the hybrids were secreting regulatory factors which could 
in any way modify a normal human antibody response. 
3.5.1 Human antibody assay (pokeweed mitogen-dependent) 
(a) Antibody tracers 
The chloramine T method of Hunter (1974) was used to iodinate 
the tracer antibodies (Goat anti-human IgG or IgM) used in the RIAs. Immediately 
following the iodination, free and bound 125 1 label was separated on a G50 gel 
filtration column. Figure 3.8 describes a typical separation profile obtained for 
the iodination of 50jJg GaHu IgG using 0.5mCi Na 1251. Peak 1 contained the 
labelled antibody and a pool of these active fractions was made. The protein 
content was estimated from the A2 8 0 using an IgG or IgM standard curve. 
the 
Specific activities of th"e radioisotope 
following relat ionships: 
(1) radioactivity (dpm) = 
(2) specific activity = 
preparations were calculated from 
observed count rate (cpm) 
efficiency 
total dpm (jJCi) 
total protein (jJg) 
Specific activities, at the time of preparation, were routinely between 8-12 
jJCi/jJg with a total protein recovery of 30-55% (6 experiments). 
FIGURE 3.8 
RADIOACTIVITY PROFILE OF G50 PURIFIED 12sI-GOAT 
ANTI - HUMAN IgG 
10 
Fraction number 
Typical separation profile of 50~g 12SI _G a Hu IgG chromatographed on a Sephadex G50 
column (1.5 x 12cm). A pool of the most active fractions was made (Peak 1) and 
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the protein concentration determined to enable the calculation of the specific activity 
of the preparation. 
(b) Antigen concentation 
Figure 3.9 describes the ant i-hapten responses obtained when 
varying concentrations of DNP-BSA or DNP-KLH were cultured with PBLs in 
the presence of PWM. The levels of specific anti-hapten antibody produced in 
response to PWM alone is also shown. A broad response peak was evidentr 
with the optimal response being at O.l)Jg/ml. Significant levels of anti-hapten 
antibody were produced in response to PWM alone. 
FIGURE 3.9 
ANTIGEN CONCENTRATION USED FOR OPTIMAL HUMAN 
ANTIBODY RESPONSE 
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Anti-hapten antibody responses obtained with PBLs ( I x I06/ml ) cultured in the presence 
of PWM and varying concentrations of antigen. 
Antigens used were: 
~ DNP-BSA 
~ DNP-KLH 
o PBLs + PWM 
II PBLs alone 
Standard deviations from triplicate determinations are shown. 
(c) Cell concentration 
Varying numbers of PBL (0.25 - 5.0 x 10 6 ) were cultured with 
DNP-BSA and PWM. Figure 3.10 shows that the peak of the response was at a 
cell concentration of 1.0 x 10 6 /m!. Culturing PBLs in the absence of antigen or 
PWM failed to produce significant levels of antibody. Culturing PBLs with PWM, 
again produced significant amounts of hapten-specific antibody, with the peak of 
the response being at cell concentration between 1.0 and 1.5 x 10 6 /ml. 
FIGURE 3.10 
CELL COI\lCENTRA TI0N USED FOR OPTIMAL HUMAN 
ANTIBODY RESPONSE 
Anti-hapten antibody responses obtained /106 cells with varying numbers of PBL cultured 
in the presence of DNP-BSA and PWM or PWM alone. 
e---. DNP-BSA + PWM III PBLs alone 
0--0 PWM alone 
Standard deviations from triplicate determinations are shown. 
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(d) Alternatives to polyclonal activation with pokeweed mitogen 
PBLs were cultured with IL-2, hydrocortisone and DNP-KLH 
or with DNP-KLH alone. All cultures were performed with and without PWM 
and control cultures utilised PBLs cultured with and without PWM. Figure 3.11 
indicates that both IL-2 and hydrocortisone enhanced hapten-specific and total 
19M antibody production in the presence of PWM, but antigen plus PWM still 
5Z. 
gave the best hapten-specific IgM antibody response. Interestingly, PBLs 
cultured with Df\IP-KLH and IL-2 alone produced significantly higher levels of 
total IgM antibodies compared with the other cultures, even though this regime 
produced only comparable levels of hapten-specific IgM antibodies. 
FIGURE 3.11 
IL-2 & HYDROCORTISONE EFFECTS ON HUMAN ANTIBODY 
RESPONSES 
PBl 
PBl + Il2 + ONPKlH 
PBl + HC + ONPKlH 
PBl + ONPKlH 
Anti ONP cpm I\" cpm t SO) 
o 500 1000 1500 2000 
PBl + PWM ~~~~~~~;;": PBl + PWM + ONPKlH 
PBl + PWM + HC + ONPKlH 
PBl + PWM + Il2 + ONPKlH 
Total IgM cpm I,cpm t SO) 
1000 2000 3000 4000 5000 6000 
Anti-hapten and total 19M antibody responses of PBLs (1 x 106/ml ) cultured under the 
conditions indicated in the diagram. 
1L-2 
DNP-KLH 
He 
(1:10) 
(O.l).lg/ml) 
hydrocortisone (10~5M) 
standard deviations from triplicate determinations are shown. 
The optimal cell culture conditions chosen were therefore at a cell 
concentration of 1 x 10 6 /ml, antigen concentration of 0.1 ).lg/ml with PWM 
at 1 ).lg/ml for 6-7 days. 
(e) Validation of the radioimmunoassay 
Three methods were used to validate the PWM-driven 
culture system and RIA. 
(i) Dose response curve 
Figure 3.12 describes the dose response curve obtained 
when supernatants from PBLs cultured with DNP-KLH and PWM were serially 
diluted and assayed for total IgG or 19M antibodies using the RIA. 
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FIGURE 3.12 
RIA DOSE RESPONSE CURVES 
4 8 16 
dilution 
32 64 128 
Dose response curves of serially diluted supernatants from PBLs (1 x l06/ml ) cultured with 
DNP-KLH (O.lWg/ml) and PWM. 
A.----.A. Total IgM antibodies 
a--tI Total IgG antibodies 
(ii) Inhibit ion curve 
As Figure 3.13 shows/ good inhibition of binding occurred 
as increasing amounts of hapten-carrier (DNP-BSA) were titrated into the 
supernatants. Significant levels of inhibition of binding occurred when carrier 
alone (KLH), was titrated into the supernatants; indicating that the PWM had 
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induced the production of both carrier-specific and hapten-specific antibodies. 
An unrelated, non-haptenated protein, ovalbumin, had little effect on binding. 
FIGURE 3.13 
COMPETITIVE INHIBITION STUDIES OF CULTURE 
SUPERNATANTS 
2-0 
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ug added 
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Inhibition of binding of supernatants from PBLs (1 x 10G/ml) cultured with IL-2 (1:10), 
DNP-KLH (O.l~g/ml) and PWM which had been titrated with increasing amounts of : 
0---0 ovalbumin 
~ KLH 
~ DNP-BSA 
Anti-hapten antibody responses shown. 
minations are shown. 
Standard deviations from triplicate deter-
(iii) IgG standard curve 
Dilutions of a known serum IgG standard were assayed in 
the RIA using polyv inyl plates coated with goat ant i-human IgG at a concentrat-
ion of 2~g/ml (lOOng IgG/well). As Figure 3.14 describes, the maximal binding 
of the test IgG standard occurred at equivalence (100ng IgG added). Above or 
O.J. 
below the equivalence point decreased amounts of the standardised serum IgG 
were bound to the coated plates as detected by the 12 51-labelled secondary 
antibody. 
FIGURE 3.14 
RIA IgG STANDARD CURVE 
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1·0 
o 0·1ng 1·0ng 10ng 100ng 1ug 
Amount IgG /50ul 
10ug 100ug 
Standard curve of IgG concentration versus 125 I G ex Hu IgG cpm bound. Polyvinyl plates 
were coated with 2~g/ml (lOOng/well) G ex Hu IgG. 
Standard deviations from triplicate determinations are shown. 
3.5.2 Human hapten-specific antibody responses 
A second, mitogen-independent, antibody assay and RIA system was 
developed. This hapten-specific antibody culture system was optimised and the 
specificity of the RIA was confirmed. 
(a) T and B cell purifications 
Figure 3.15a shows that a maximum of 3% T cells were present 
in the purified B cell population. Figure 3.15b indicates that less than 2% 
B cells were present in the purified T cell population. 
.... 
<II 
.0 
E 
:::I 
c: 
o 
FIGURE 3.15 
FACS PROFILES OF T & B CELL PREPARATIONS 
USED IN THE ANTI -HAPTEN ANTIBODY 
ASSAY 
a . 
3% 
100 
Channel number 
200 o 
b. 
2% 
100 
Channel number 
200 
a. Fluorescence profile of purified B cells stained with anti-T cell McAb Leu-I. 
b. Fluorescence profile of purified T cells stained with goat anti-human 19. 
(b) In vitro anti-hapten responses 
The optimal antigen concentration, cell concentration and 
kinetics for the generation of anti-hapten antibodies were determined. 
(i) Antigen concentration 
00. 
One million cells/O.2ml were cultured in the range of 
O.1-50~g of antigen. Figure 3.16 shows the optimal anti-hapten response was 
at an antigen concentration of 1.0~g/O.2ml culture. At higher antigen concen-
trations a marked reduction in anti-hapten antibody production was observed. 
FIGURE 3.16 
ANTIGEN CONCENTRATION USED FOR OPTIMAL ANTI-HAPTEN 
ANTIBODY RESPONSE 
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Anti-hapten antibody responses obtained with PBLs (1 x l06/0 •2ml ) cultured in the presence 
of varying concentrations of antigen. 
Antigens used were: 
e- -e DNP-BSA 
~ DNP-KLH 
Standard deviations from triplicate determinations are shown. 
(ii) Cell concentration 
Varying numbers of PBLs (0.5 - 20.0 x 10 5 ) were cultured 
with DNP-BSA, DNP-KLH (l.O"flg/ml) or without antigen as described. Figure 
3.17 shows that the optimal cell density was at 1.0 x 10 6 cells/0.2ml culture. 
Above or below this density decreased amounts of specific antibody was produced. 
FIGURE 3.17 
CELL CONCENTRATION USED FOR OPTIMAL ANTI-HAPTEN 
ANTIBODY RESPONSE 
3.0 
00.5 1.0 5.0 10.0 20.0 
Cell no. x 105 
Anti-hapten antibody responses obtained with varying numbers of PBLs cultured in the 
presence of DNP-BSA, DNP-KLH (l.O~g/ml) • 
• - -. DNP-BSA 
.a.----... DNP-KLH 
Standard deviations from triplicate determinations are shown. 
(iii) Kinetics 
88. 
The kinetics of the anti-hapten response was studied by 
determining the levels of anti-hapten antibodies in the culture supernatants at 
the times indicated in Figure 3.18. The supernatants were harvested at the 
relevant times and frozen at -20°C until assayed as one batch in the same RIA. 
Figure 3.18 shows that the peak of the anti-hapten response was between days 
5 and 7. 
FIGURE 3.18 
KINETICS OF ANTI-HAPTEN ANTIBODY RESPONSE 
M , 
3.0 
~ 2.0 
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3 5 7 9 12 
Days in culture with antigen 
PBls (l x lOG 10. 2m!) were cultured with DNP-BSA, DNP-KlH (l.0}1g/0.2ml) for various 
intervals. On days 1, 3, 5, 7, 9 and 12 culture cells were washed 3 times with fresh 
medium and cultured for a further 4 days in the absence of antigen. These culture 
supernatants were stored at -20ne until assayed in the anti-hapten antibody RIA • 
• - -. DNP-BSA 
Ar----A DNP - Kl H 
~ .... ·x PBls alone 
89. 
The optimal culture conditions chosen therefore were at a cell concentrat-
ion of 1 x 10 G/0.2ml, antigen concentration of 1.0}1g/0.2ml and 5 days in culture 
with antigen followed by 4 days without antigen. 
(c) T cell dependence of anti-hapten response 
Figure 3.19 shows the maximal response was obtained when 
equal numbers of Band T cells were present in the culture (5 x 10 5 of each). 
B or T cells alone gave a minimal response to antigen. Increasing the numbers 
of T cells up to equivalence had an amplifying effect on the anti-hapten 
response whereas the addition of extra T cells, greater than 5 x 10 5, markedly 
reduced the anti-hapten response. 
FIGURE 3.19 
T CELL DEPENDENCE OF ANTI-HAPTEN RESPONSE 
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Varying numbers of purified T cells were cultured with a constant number of purified 
B cells (5 x 105 ) and DNP-BSA (l.0~g/0.2ml). The anti-hapten antibody responses 
obtained for the various T and B cell combinations are shown. 
Standard deviations from triplicate determinations are shown. 
(d) Specificity of the radioimmunoassay 
The specificity of the anti-hapten antibody RIA was confirmed 
by titration of anti-hapten culture supernatants with hapten-carrier conjugate or 
ovalbumin. 
As Figure 3.20 showst good inhibition of binding occurred as increasing 
amounts of DNP-BSA were titrated into the supernatants. A non-haptenated 
proteint in this case ovalbumint had little effect on binding. 
FIGURE 3.20 
SPECIFICITY OF ANTI-HAPTEN ANTIBODY RIA 
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Inhibition of anti-hapten antibody binding to DNP-BSA-coated plates. Supernatants from 
PBls (1 x IOG/O.2mI) cultured with DNP-BSA (I.O~g/O.2mI) were titrated with increasing 
amounts of : 
x----x ovalbumin 
.. - -.. DNP-BSA 
standard deviations from triplicate determinations are shown. 
3.6 HUMAN T CELL HYBRID FUNCTIONAL STUDIES 
'f I • 
3.6.1 Effect of hybrid-derived supernatants on a PWM-induced polyclonal 
antibody response 
Preliminary experiments indicated that hybrid-derived supernatants 
from all four lines were capable of suppressing, to varying extents, the PWM-
induced antibody response of the normal indicator lymphocytes. Hybrid line TT-4 
had the most potent suppressive effect on the generation of polyclonal IgG anti-
body, therefore it was this line which was investigated in depth. 
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(i) Const Hut ive lymphokine production 
TT -4-derived supernatants were assayed for their ability to 
suppress the PWM-induced antibody assay. 
Figure 3.21 describes the curve of % suppression of the PWM-induced IgG 
production versus dilution of supernatant for the three cell concentrations tested. 
Figure 3.21 shows a dose and producer cell concentration dependent suppressive 
effect of the TT -4 supernatants on the generation of an in vitro PW M-induced 
polyclonal IgG antibody response. Suppression of between 19% (0.5 x 106/m l, 
1 :50 dilution) and 75% (5.0 x 10 6/ml, 1:2 dilution) was achieved. This suppress-
ion corresponds, in ng IgG, to a reduction from 32ng IgG produced in response 
to the mitogen down to 7ng at 5.0 x 106/ml (l :2) and 26ng at 0.5 x 10 6 /ml 
(1 :50) 
The level of stimulation of the indicator PBLs, from 6.8 ± 0.2ng when 
cultured in the absence of PW M, to 32 ± 1.5ng IgG in the presence of PW M, 
indicated that a significant level of mitogenesis of the indicator PBLs had 
occurred. A suppression of this response, by up to 75%, indicated that hybrid-
derived supernatants from the TT -4 line could exert a potent regulatory 
effect on the generation of an in vitro PWM-induced antibody reponse. 
FIGURE 3.21 
EFFECT OF TT -4 SUPERNATANT ON A PWM-INDUCED 
ANTIBODY RESPONSE 
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Results expressed as % suppression ± SD (triplicate determinations) of the response 
obtained with PWM alone - background (PBls + PWM; 32 ± 1.5 ng IgG, PBls alone; 
6.8 ± 0.2ng IgG). 
Control supernatants derived from CCRF-CEM cells or normal PBl cultures had only a 
minimal effect on the PWM-induced antibody response. 
Cell concentrations of hybrid-derived supernatants added to assay: 
~ 0.5 x 10G/ml 
It---II 1.0 x lOG /ml 
~ 5.0 x 10G/ml 
(ii) Hybrid induction 
o PBls + PWM 
D PBls alone 
Supernatants, derived from TT -4 hybrid cells which had 
been pretreated with ConA were screened in the human antibody assay. 
Figure 3.22 indicates that the addition af supernatants derived fram 
93. 
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from unstimulated hybrid cells (lines 8 & 12) resulted in a significant reduction 
in the levels of IgG ant ibody produced in response to PW M (28 & 24% 
suppression respectively). Control cultures (lines 2-7) utilising PBLs cultured 
with varying concentrations of ConA, in the presence and absence of PW M, 
led to a reduct ion in the levels of IgG produced by the indicator PBLs (11 to 
23% suppression, lines 2 & 6). 
Induction of the hybrid cells with increasing amounts of ConA (1, 5 or 
lO]Jg/ml) did not result in increased levels of suppression of the PWM-induced 
IgG response compared to supernatants derived from non-induced hybrid cells. 
At a hybrid cell concentration of 0.5 x l06/m l (lines 8-11) stimulation with 
ConA resulted in marginally less suppression of the PWM-induced antibody 
response (25-27% suppression cf 28% for non-induced hybrids). For the hybrid 
cells grown at 1.0 x 10 6/ml (lines 12-15), induction with ConA had no 
significant effect on the ability of the hybrid-derived supernatants to suppress 
the PWM-induced antibody response of the indicator PBLs. 
The experimental results presented in Section 3.6.1 indicated therefore 
that the TT -4 hybrid line was able to exert a potent suppressive effect on 
the generation of antibody by normal indicator B cells in response to the 
polyclonal activator pokeweed mitogen. This suppressive effect of the 
hybrid-derived supernatants was not dugmented if the hybrid cells were 
stimulated with concanavalin A prior to the collection of the hybrid supernat-
ants. 
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FIGURE 3.22 
ConA-INDUCTION OF TT -4 HYBRID CELLS 
3·0 
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Effect of supernatants derived from eonA-treated TT-4 hybrid cells on a PWM-induced 
antibody response. Results expressed as anti-IgG cpm x 10-4 (± SD of triplicate 
determinations). 
The effects of varying concentrations of eonA on the normal PWM-induced antibody 
response (No.1) are shown in Nos. 2-7. The effects of supernatants derived from 
hybrid cells grown at 2 cell concentrations and pre-induced with 1-IOwg/ml eonA 
on the PWM-induced antibody response (No. 8-15) are shown. 
3.6.2 T cell proliferative responses 
Supernatants, derived from TT -4 hybrid 'cells were screened in the 
T cell proliferation assay. 
The indicator cells were 48 hr PHA-stimulated PBLs cultured for a further 
48 hrs in the presence of hybrid supernatant, with and without exogenous IL-2 
(1: 10 dilut ion). 
Figure 3.23 indicates that significant suppression of this IL-2 driven T cell 
proliferative response occurred at dilutions of 1:2 and 1 :4. Suppression of the 
J 
I----! 
response was obtained at J:8 for hybrid cells grown at 5.0 x 10 6 1m!. The 
suppression was therefore dose and cell concentration dependent. 
FIGURE 3.23 
EFFECT OF TT -4 SUPERNAT ANTS ON T CELL PROLIFERA nON 
IN THE PRESENCE OF IL-2 
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Effect of TT-4 supernatants on a T cell proliferative response. 
Results expressed as 
'16. 
'H-TdR uptake (cpm x 10- 4 ) by 48 hr PHA-stimulated PBLs in the presence of IL-2 (1:10) and 
dilutions of TT-4-derived supernatants. PHA-stimulated PBLs were cocultured with the 
supernatants and IL-2 for a further 48 hrs, then pulsed for 16 hr with 2.0~Ci JH_ TdR. Cells 
were harvested onto glass fibre filters and counted by liquid scintillation. 
Cell concentrations of hybrid-derived supernatants added to assay: 
~ 0.5 x 106/ml 
S--III 1.0 x 10 6 / ml 
~ 5.0 x 106/ml 
o 4B hr PHA-PBLs + IL-2 (1:10) 
Standard deviations from quadruplicate determinations are shown. 
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Figure 3.24 describes the response obtained when 48 hr PHA-stimulated 
PBLs were cocultured with hybrid supernatant in the absence of exogenous 
lL-2. The level of proliferation, again assessed by JH_ TdR uptake, was 
significantly reduced in the absence of exogenous IL-2 (1735 ± 500 cpm cf 
72000 ± 5000 cpm in the presence of IL-2). At hybrid supernatant dilutions 
of 1:4 and 1:8 the JH_ TdR uptake increased 2-3 fold. Some amplification of 
the response was therefore obtained, but this was only minimal when compared 
to the effect of exogenous IL-2. 
The results presented in Section 3.6.2 indicated that TT -4 supernatants 
could suppress the proliferative response of lectin-activated T cells to 
exogenous IL-2. Several possibilities exist as to the mode and site of action 
of the hybrid-derived activity in suppressing this T cell response and these 
will be discussed in Chapter 4. 
FIGURE 3.24 
EFFECT OF TT -4 SUPERNATANTS ON T CELL PROLIFERA nON 
IN THE ABSENCE OF IL-2 
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Dilution of supernatant 
'H-TdR uptake (cpm x 10- 3 ) by 48 hr PHA-stimulated PBls in the presence of TT-4 
supernatants without exogenous Il-2. PHA-stimulated PBls were cocultured with the 
supernatants for a further 48 hrs, pulsed with 2.0~Ci 'H-TdR for 16 hrs and counted 
by liquid scintillation. 
Cell concentrations of hybrid-derived supernatants added to assay: 
0----0 0.5 x 106 /ml 
II1----II 1. 0 x 10 6 I ml 
..t.---.it. 5.0 x 10 6 Iml 
o 48 hr PHA-PBls alone 
Standard deviations from quadruplicate determinations are shown. 
'lB. 
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3.7 PRELIMINARY BIOCHEMICAL STUDIES OF HYBRID-DERIVED FACTORS 
It was possible that the biological effects of the TT -4 line were due to 
more than one regulatory molecule present in the hybrid supernatant. 
Preliminary biochemical characterisation of the TT -4 supernatants was therefore 
undertaken. Gel filtration chromatography was performed to determine: 
1) the apparent MW of the suppressor activity, and 
2) to investigate whether one or more activities were 
present in the hybrid supernatants. 
3.7.1 ARparent Molecular Weight 
A Sephacryl S-200 column packed and equilibrated 'with PBS pH 7.4 
was calibrated using known M W protein standards. Blue dextran was used to 
estimate the void volume. 
A selectivity (or calibration) curve was constructed from a plot of Kav 
versus log MW. Figure 3.25 describes the elution profile for the MW standards 
used and Figure 3.26 is the calibration curve of the Kav verses log MW for the 
protein standards. 
FIGURE 3.25 
ELUTION PROFILE OF S-200 CHROMATOGRAPHED MW STANDARDS 
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A 90 x 2.6cm column packed with Sephacryl S-200 was calibrated with known MW protein 
standards. Flow rate = 15ml/hr. Buffer = PBS pH 7.4. 
Protein standards were: lmg each of catalase (210 Kdal), phosphorylase b (97), BSA (67), 
ovalbumin (43) & myoglobin (17). The void colume was estimated with blue dextran 
(> 2.5 x 105 Kdal). 
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FIGURE 3.26 
$-200 MW CALIBRATION CURVE 
1 x105 
logMW 
1 x106 
Calibration curve of Kav versus log MW constructed from the elution volumes of the 
protein standards and blue dextran. Kav calculated from the following relationships 
Kav = Vt - Vo where; 
Kav = fraction of stationary gel volume which is available for diffusion of a given 
solute species. 
Vo = void volume, the elution volume of molecules which are only distributed in the 
mobile phase because they are larger than the largest pores in the gel. 
Ve = elution volume of a particular molecular species. 
Vt = total volume of the gel bed. 
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Pooled concentrated fractions (corresponding to different MW ranges) from 
$-200 chromatographed TT -4 supernatant were assayed in the T cell proliferation 
assay at a final dilution of 1:4 and produced 3 major peaks of suppressive 
activity (Figure 3.27). These corresponded to greater than 250 Kdal (Vo), 
120-140 Kdal and 60-80 Kdal. Concentrated pre column TT -4 supernatant gave 
53 ± 3% suppression at a final dilution of 1 :4. 
FIGURE 3.27 
EFFECT OF CHROMATOGRAPHED TT -4 SUPERNATANT FRACTIONS 
ON A T CELL PROLIFERA liVE RESPONSE 
x 
50 
c: 40 
.2 
(/) 
(/) 
Il) 30 
"-0-
n 
::I 
(J) 20 
'#. 
10 
0 
0 0 0 0 0 0 0 0 0 0 0 0 
+10 \.0 \.0 0 (0 '<t N 0 a:J (0 '<t N 'I N N N .... .-
- 'I I I I I I I I I I 0 0 0 0 0 
0 0 0 0 0 0 (0 '<t N ... 
0 (0 '<t N 0 a:J 
N -
.- .... 
MW range (kdal) 
Results expressed as r. suppression ± so (triplicate determinations) 
= (Column fraction cpm) 
( 2 PHA-PBL + IL-2 cpm) -
(PHA-PBL alone cpm)l 
1 (PHA-PBL alone cpm) 
1. 48 hr PHA-stimulated PBLs, no exogenous IL-2 (PHA-PBL alone 
= 17000 ± 750 cpm) 
2. 48 hr PHA-stimulated PBLs + 1:10 partially purified IL-2 
(PHA-PBL + IL-2 = 167000 ± 8900 cpm) 
X Precolumn TT-4 supernatant, 1:4 final dilution. 
Figure 3.28 describes the elution profile of the chromatographed TT-4 
supernatant before the fractions were pooled, concentrated and assayed in 
the T cell proliferation assay. 
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90ml of TT-4 supernatant was concentrated to 6.5ml by ultra-filtration over a P5AC - 10' 
MW membrane. 5ml of this concentrated supernatant was chromatographed on the calibrated 
5-200 column. Flow rate = 15ml/hr. 5ml fractions were collected. 
3.7.2 Physicochemical characterisation 
Several physicochemical characteristics of the hybrid-derived 
activity were investigated. 
Table 3.8 describes the physicochemical characteristics of the TT-4 
supernatants. TT -4 was partially labile at both pH 2.0 and pH 9.0 
(9.4 ± 2.8 and 4.0 ± 3.0 % suppression respectively cf 33.0 ± 3.0% suppression 
of the T cell proliferative response by untreated supernatants). 50mM 
dithiothreitol reduced the suppression from 33.0% down to 8.4 ± 4.0%. 
a - methyl mannoside, L-fucose and N-acetyl glucosamine decreased the 
suppression from 33.0% in the controls to 6.9 ± 6.5, 10.5 ± 7.5 and 
10.2 ± 6.1 % respectively. Interestingly, L-rhamnose had no significant effect 
on the TT -4 suppression of T cell proliferation (24.8 ± 6.4 cf 33.0 ± 3.0%). 
3.8 
BIOCHEMICAL CHARACTERISATION OF TT -4 SUPERNATANT 
ACTIVITY 
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Treatment of 
supernatant IjJ 
Control cpm 
(± SD) 6 
Experimental 
cpm (± SD) 
% suppression 
(± SD) f... 
Untreated 194439 (10000) 130325 ( 5895) 33.0 (3.0) 
pH 2.0 126866(9719) 115031 ( 3595) 9.4 (2.8) 
pH 9.0 222939 ( 3797) 213540 ( 6874) 4.0 (3.0) 
DTT 190555 ( 7903) 175000 ( 7731) 8.4 (4.0) 
L-rhamnose 201754 (10571) 152162 (13034) 24.8 (6.4) 
a-methyl mannoside 187889 (15754) 174689 (12322) 6.9 (6.5) 
L-fucose 208992 (15885) 187389 (15754) 10.5 (7.5) 
N-acetyl glucosamine 215419 (14603) 193770 (13210) 10.2 (6.1) 
The assay utilised 48 hr PHA-stimulated PBLs + 1:10 partially purified IL-2 
+ control or test supernatant. 
IjJ see Section 2.7.2 for treatment of TT-4 supernatant. 
6 all controls utilised RPMI, 15% FCS treated in an identical manner to the TT-4 
supernatant. 
~ data expressed as: 
% suppression ± SD = 1 (Experimental TT-4 supernatant cpm) - (background cpm) 
(Control Supernatant cpm) 1 - (background cpm) 
1 Background cpmj 48 hr PHA-stimulated PBLs, no exogenous IL-2 = 430 ± 35 cpm. 
CHAPTER 4. 
DISCUSSION 
The significance of the experimental techniques developed and data 
presented in this thesis will be discussed under the following sections 
4.1 Introduction and aims of experimental work. 
4.2 Characterisation of mutagenised hybrid parental lines. 
4.3 Human T cell hybrids: establishment, selection and 
cr iter ia for hybridisat ion. 
4.4 Functional assays: development and validation. 
4.5 Functional studies of human T cell hybrid lines. 
4.6 Biochemical characterisation of hybrid-derived factors. 
4.7 Biological significance of T cell hybrid-derived suppressor 
factor. 
4.8 Future studies. 
4.1 INTRODUCTION AND AIMS 
Detailed investigations of the structure-function relationships and the 
biological significance of lymphokine regulation of human immune responses 
have until recently been difficult. Many of the biological effects, as well as 
lUll-. 
an appreciation of the pivotal role T cell-derived lymphokines play in immune 
regulation are known (see Immunological Reviews 63), but the biochemical 
nature and mechanism of action of these "immunological hormones" are still 
largely unknown. These deficiencies in aur knowledge result, in part, from the 
limitations imposed by conventional lymphokine preparations i.e. the heterogen-
eous nature of the producer cell population and the limited amounts available 
for detailed biochemical analysis. These shortcomings will only be overcome 
when stable and homogeneous T cell lines secreting distinct, or restricted 
numbers of lymphokines are established. 
Three major approaches are currently being used to create homogeneous 
and stable lymphokine-secreting T cell lines. These techniques are: 
l} the adaptation of T cell leukemias and lymphomas to 
growth in culture, 
2) the maintenance of normal T cells in culture by the 
addition of II growth factors" and, 
3) immortalising T cell funct ion by fusing normal lymphokine-
secreting T cells with a neoplastic T cell line. 
I U:J. 
This thesis has addressed the problem of creating stable sources of human 
T cell-derived regulatory lymphokines by utilising the third of these approaches. 
The techniques of somatic cell hybridisation, as refined by Kohler & Milstein 
(1975) for the construction of murine B cell hybridomas secreting monoclonal 
antibodies, have been adapted for the production of human T cell hybridomas 
(Grillot-Courvalin et aI, 1981; Irigoyen et ai, 1981). Fusion of lectin-activated 
T cells with a drug-resistant leukemic T cell line aims to immortalise normal 
T cell secretory activity on a background of continued proliferation by the 
leukemic T cell. 
Human T cell hybrid lines were constructed between a 6TG-resistant human 
T -ALL line and ConA-activated normal human PBLs using PEG as the fusigen. 
Select ion of T cell hybrids was achieved by a combined approach which ut ilised 
both drug and phenotype selection (Sections 2.2, 2.3). Selection systems are 
necessary to ensure that "true" hybrids, arising from only drug-resistant tumor 
cells and that lectin-activated T cells are produced. In contrast to B cell 
hybrids, where the success of the fusion can be assessed with relative ease by 
screening the derived lines for the production of antibodies of unique specificity, 
T cell hybrids pose special problems. Short-term RIA or ELISA tecnhiques can 
be used to assess if the drug-selected B cell hybrids are producing monoclonal 
antibodies not secreted by the parental tumor line and which therefore must be 
derived from the genetic contribution of the normal B cell to the hybrid. Short-
term assay systems such as these enable the selection of hybrid clones based on 
functional activity. Similar short-term assays confirming functional hybridisation 
in human T cell hybrid lines are not currently available. For this reason long-
term assays are required to screen T cell lines for biological activity (Section 
2.6.2). To increase the frequency of true human T cell hybrids arising from 
the fusions, and therefore the likelihood of establishing lines with immimoregulat-
ory activity, two selection systems were used. The HAT drug system was used 
to select for hybrids resulting.from the fusion of the HGPRT- parental tumor 
line X HGPRT+ normal T cells (rationale explained in Section 1.8.2). A second 
approach utilising the cell surface phenotype of the resultant hybrids was also 
adopted. Acquisition of a marker, absent on the parental tumor line and 
subsequently expressed on the putative hybrid cells, allowed the isolation of 
true hybrid cells. This double selection approach was successful in establish-
ing human T cell hybrid lines possessing immunoregulatory activity. 
I06~ 
Extensive characterisation of the human T cell lines was undertaken and 
one hybrid line, TT -4, was shown to elaborate a soluble factor which suppressed 
both B cell antibody and T cell proliferative responses. Preliminary character-
isation of this hybrid-derived suppressive activity was undertaken. 
The following sections of this chapter discuss the significance of these 
studies. 
4.2 CHARACTERISTICS OF MUT AGENISED HYBRID PARENTAL LINES 
A 6-thioguanine-resistant line, CEM-6TGR, derived from the human T -ALL 
line CCRF-CEM was produced." CEM-6TGR was used as the primary hybrid 
parental tumor line for the construction of human T cell hybrids. Cell lines 
resistant to 6TG have been shown to be deficient in the salvage enzyme HGPRT 
(Sato et aI, 1972) and are therefore killed in the HAT selective media devised 
by Szybalski et al (1962). The HAT system was used to select for putative 
hybrid cells arising from the PEG-induced fusion of ConA-activatednormal 
human PBLs with the CEM-6TG R line. 
CEM-6TGR was established by treating CCRF-CEM cells with the mutagen 
EMS, and subsequent selection in 6TG-supplemented tissue culture medium. 
EMS is a guanine base-specific alkylating agent which results in the formation 
of a quarternary nitrogen which destabilises the deoxyriboside link thus releasing 
the deoxyriboside (Conn & Stumpf, 1972). Loss of a base can lead to its 
replacement by any of the four bases or even rupture of the DNA, hence its 
powerful mutagenic properties. Albertini & De Mars (1970) and Sato et al 
(1972) have shown that mutagenised cells resistant to BAG or 6TG are deficient 
in HGPRT activity. Normal wild type (HGPRT+) cells are killed because these 
drugs when metabolised interfere with normal nucleotide and nucleic acid 
synthesis. The uptake in metabolism of these nucleotide analogues is mediated 
by the HGPRT enzyme which converts the drugs to abnormal metabolites. 
Mutant cells which lack the HGPRT enzy"riie are resistant to 6TG and therefore 
survive the treatment. 
Following EMS mutagenesis of CCRF-CEM cells, the 6TG supplement added 
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to the culture medium was added stepwise from 0.1-18]lg/ml over approximately 
six weeks. The data presented in Table 3.1 indicate that a maximum of 56 % of 
the cells survived the initial EMS treatment (l]lg/ml) compared to 85% in control 
cultures. These results compare favourably with the data described by other 
workers also studying mammalian cells. 
Kao and Puck (1968) using Chinese hamster ovary cells, demonstrated that 
the survival curve for EMS treatment has a large initial shoulder. At concen-
trations of up to 100]lg/ml, reasonably high levels of cell survival were achieved 
(up to 78%). In contrast, Sato et al (1972), mutagenised a human lymphoblastoid 
cell line with varying concentrations of EMS and demonstrated that at 50]lg/ml, 
approximately 30% of cells survived a 24 hr treatment (cf 38% in this study). 
Sato et al also estimated the plat ing efficiency of EMS-treated and untreated 
cells in the presence of varying concentrations of 6TG. In the absence of EMS 
mutagenesis, 6TG concentrations greater than 1 ]lg/ml resulted in no 6TG-
resistant colonies arising in culture. Following EMS mutagenesis though, the 
frequency of 6TG-resistant mutants obtained was increased 109-fold (to approx. 
2 x lO-lf/cell/generation), over the spontaneous frequency of 6TG-resistant cells 
arising. EMS was therefore shown to be of value in the induction of 6TG-
resistance in these human cells. 
Twenty-four hour EMS-mutagenesis followed by 6TG-selection (0.1 ]lg/ml) 
was shown in this study to enable the construction of the CEM-6TGR line. This 
drug-resistance was subsequently demonstrated to be due to a significantly 
reduced level of functional HGPRT activity when compared to the parental 
CCRF-CEM line (Section 2.5). 
Thioguanine was observed to have a significant inhibitory effect on the 
growth of the EMS-treated cells until some 20 days post mutagenesis. One 
mutagenised line, (10]lg/ml EMS) regained its normal growth characteristics in 
the presence of 6TG after the initial drug "shock", and it was this line which was 
further selected with increasing concentrations of 6TG up to a maximum of 
18]lg/ml. This line was termed CEM-6TG R and was used as the drug-resistant 
hybrid parental line for the construction of human T cell hybrids. 
CEM-6TGR cells were maintained in the presence of 6TG to ensure that 
any rare revertants to HGPRT+ cells did not arise in culture. Revertant cells 
survive in HAT -supplemented selective media and could possibly overgrow any 
true hybrids. Fortunately the frequency of revertants arising in culture is very 
low «10- 7 ) (Morrow et aI, 1982), and does not therefore constitute a major 
limitation of somatic cell hybridisation studies. 
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CEM-AG R, an 8-azaguanine-resistant derivative of CCRF-CEM, kindly 
provided by Professor T. Kishimoto (Osaka), was used for some fusion experiments. 
Growth rates of CEM-6TGR, CEM-AGR and the non mutagenised CCRF-CEM 
line were determined. The estimated doubling times for these lines were 30, 28 
and 26 hrs respectively. Both drug-resistant lines therefore exhibited doubling 
times comparable to that of the parental CCRF-CEM line. Doubling times for 
CCRF-CEM (26 hrs) are comparable to that quoted by Greene et al (1982) (24 hrs) 
but considerably less than that described by Foley et al (1965) (46 hrs). It is 
important to note that the study by Foley et al related to a diploid clone of the 
CCRF-CEM line at a time when it was probably still adapting to growth in vitro. 
Growth inhibition after 120 hrs (2 x 1Q5/ml) for CCRF-CEM and 140 hrs (2 x 106/ 
ml) for CEM-AGR was observed. 
Terminal deoxynucleotidyl transferase (TdT) is a DNA polymerase which is 
regarded as a marker for primitive lymphocytes in the hematopoietic system 
(Janossy et aI, 1979). Both the CCRF-CEM and CEM-6TGR lines were TdT- as 
assessed by the fluorescent ant ibody technique descr ibed. T dT+ control cell lines 
stained simultaneously were TdT+, minimising the possibility of a technical failure. 
Subsequent staining of the lines has confirmed these observations. CCRF-CEM is 
regarded as an early T -ALL and has been previously demonstrated to express the 
TdT marker (Janossy et aI, 1979). Failure to detect the TdT marker may be 
consistent with the observations made by Suomalainen et al (1980), that many 
established long-term leukemia lines have acquired profound aberrations in their 
chromosome sets as well as their phenotype. These observations could relate in 
this instance to the chromosome carrying the gene coding for TdT expression. 
The chromosomal analysis and phenotype studies performed on the CEM-6TGR 
line may confirm this hypothesis (Sections 3.2.1, 3.2.3). 
Growth of the CEM-6TGR line in 6TG-supplemented media suggested it was 
deficient in HGPRT activity and should therefore be killed in HAT media 
(Littlefield, 1964). HAT sensitivity experiments performed by culturing CEM-6TGR 
cells directly in this media showed that no viable cells were present after 7 days 
in culture. HAT sensitivity confirmed the CEM-6TGR line would be of use in the 
construction of human T cell hybrids. The biochemical rationale enabling the use 
of HAT media for the selection of somatic cell hybrids has been described 
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(Section 1.8.2) but briefly, parental (HGPRT-) tumor cells are killed 'in HAT and 
only hybrids which have inherited a complementary HGPRT gene from a wild 
type (HGPRT+) normal T cell are able to survive. 
4.3 HUMAN T CELL HYBRIDS: ESTABLISHMENT, SELECTION AND 
CRITERIA FOR HYBRIDISA TION 
Human T cell hybrids were established following the PEG-induced fusion of 
CEM-6TGR cells with ConA-activated normal human PBLs. PEG is almost 
universally adopted for the construction of hybrids. DMSO was added to the PEG 
fusion solution as it has been reported to decrease the hyper-osmotic effects of 
the PEG solution and enhance the PEG-mediated fusion of mammalian cells 
(Norwood et aI, 1976). 
Conventional HAT selection followed by phenotypic selection of the OKT3 
expressing hybrids by sterile cell sorting on a FACS IV was used to establish 4 
human T cell hybrid lines (TT -1 to TT -4). Phenotypic selection of the HAT-
selected hybrid cells was possible because the CEM-6TGR parental line did not 
express the antigen recognised by the OKT3 McAb and its presence on the hybrid 
cells must have therefore resulted from the contribution of the actlvated"nmmal 
T cells. Normal T cells die in culture without the addition of exogenous growth 
factors and therefore do not contribute to the HAT selected hybrid population. 
As stated, selection systems were also necessary due to the lack of short-term 
screening assays capable of detecting low levels of lymphokine secretion by the 
hybrid lines. 
Three techniques were used to confirm that If true" human T cell hybrids 
had been produced : 
4.3.1 Surface phenotype studies of parental and hybrid cells 
Surface phenotype studies were performed on both the parental and 
hybrid cells to determine if the expression of receptors, absent on the parental 
CEM-6TGR line but present on normal T cells, were subsequently expressed on 
the HAT-selected putative hybrid cells. The acquiSition of a particular cell 
surface receptor from the normal T cell and its expression on the resulting T cell 
hybrid line would therefore be indicative of true hybrid formation. Furthermore, 
the capacity of the FACS to sort, under sterile conditions, cell populations 
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possessing defined phenotypic characteristics was exploited in the establishment 
of the hybrid lines. 
Indirect immunofluorescence staining and FACS onolysis of the ConA-
activated PBL fusion partners indicated that greater than 85% were Leu-4+ 
(T cells) and less than 7% were SmIg + (B cells). Though specific enrichments 
of the normal ConA-activated T cells e.g. E rosetting, were not performed prior 
to fusion a significant level of enrichment in T cell percentages resulted from 
the lectin-activation. 
CEM-6TGR and CEM-AGR cells were screened with a wide range of mono-
clonal antibodies to human cell surface receptors. The results presented in 
Table 3.3 indicated that neither line expressed the receptor recognised by the 
OKT3 or Leu-4 McAbs. Absence of the OKT3 receptor on the CEM-6TGR line 
and its subsequent expression on the HAT-selected hybrid cells was used to set 
sorting windows on the FACS to facilitate sterile sorting of the OKT3+ hybrid 
population. OKT3 expression on the HAT-selected hybrids was deemed 
indicative of true hybrid formation between OKT3- parental tumor cells and 
OKT3+ normal lectin-activated T cells. 
Dual parameter gated analysis was used to sort the OKT3+ population whilst 
excluding non-viable and OKT3- cells (tumor x tumor hybrids and hybrids not 
expressing the receptor). 
Taniguchi & Miller (1978) have described a similar approach which allowed 
non-mutant T cell lines to be used in murine T cell hybridisation programmes. 
The selection techniques adopted in this thesis, if used in conjunction with dual 
colour fluorescence, have the potential to allow hybrid selection based on the 
expression of multiple receptors. This approach will be used in conjunction with 
specific receptor deletions (by chemical mutagenesis ax! selection) to investigate 
the relationship between receptor expression and lymphokine secretion by human 
T cell hybrids. 
The frequency of OKT3+ hybrids arising from the fusions or the frequency 
of revertants to HAT resistance has not been addressed. The lack of expression 
of the OKT3 receptor by the CEM-6TGR line coupled with positive selection of 
the OKT3+ hybrids was used to exclude the possible contribution of CEM x CEM 
revertants to the hybr id cell population. Few studies have considered the 
reversion rates of HAT-sensitive cells to HAT-resistance, but these rates have 
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been shown to be very low (Morrow et ai, 1970). 
Minowada et al (1977) reported that CCRF-CEM had lost its ability to form 
sheep rosettes. This was confirmed for both CEM-6TGR and CEM-AGR by a 
lack of reactivity with the Leu-5 McAb. Howard et al (1981) showed that the 
Leu-5 receptor is usually expressed on 95- 1 00% of human T cells. 
Membrane phenotype studies were performed on the hybrid lines from 10-140 
days post fusion. These studies showed that 2.6 - 3.0% of the putative hybrid 
cells were expressing the OKT3 marker 10 days post fusion. Relatively stable 
percentages of OKT3+ cells or an enrichment of this population had occurred 
when staining was performed 76-90 days post fusion. OKT3 staining beyond this 
time (up to 140 days) indicated that a significant loss of OKT3 receptor expression 
had occurred in all the 4 lines. Even though a loss of OKT3 receptor expression 
occurred over 3-4 months in culture, hybrid-derived supernatants still produced 
significant levels of suppression of a PWM-induced antibody response (discussed 
in Section 4.5). The expression, or lack of expression, of the OKT3 receptor by 
the lines cannot therefore be correlated direct ly with biological activity. OKT3 
expression must therefore be viewed as only an indicator of "true" hybrid form-
ation in the early stages following fusion and drug selection. 
Phenotyping hybrid cells 90 days post fusion indicated that all 4 lines 
exhibited, to varying extents, expression of both the Leu-2a and Leu-3a 
markers. The levels of expression of these markers were comparable within each 
line, but a wide variation in staining (31-80% Leu-2a +, 33-73% Leu-3a +) was 
apparent between hybrid lines. This apparent discordant expression of receptors 
has been reported in other human T cell hybridoma studies (DeFreitas et ai, 1982). 
The Leu-2a (Ts/c) and Leu-3a (Th/i) defined antigens are usually regarded as 
mutually exclusive markers of normal T cell subpopulations therefore their 
apparent dual expression on the hybrid lines suggests that the expression of these 
antigens is not regulated in T cell hybrids as they are in normal T cells. For this 
reason one must conclude that surface phenotype need not necessarily correlate 
with functional activity in human T cell hybrids. An inability to detect 
significant levels of helper activity for T cell proliferation in chromatographed 
hybrid supernatants (Section 3.6.1 (b) ) perhaps reinforces this hypothesis. 
4.3.2 Functional HGPRT activity 
Cells resistant to 6TG have been shown to be deficient in functional 
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HGPRT activity (Sato et 01, 1972) and are therefore killed in HAT-selective 
media (Littlefield, 1964). Hybrids between HGPRT- parental tumor cells and 
HGPRT+ normal T cells survive the HAT-selective media because they are able 
to bypass the aminopterin block of de novo nucleotide biosynthesis by utilising 
their restored salvage pathways. 
Deficiency in functional HGPRT activity by the parental tumor line and its 
subsequent acquisition following hybridisation would be further evidence for true 
hybrid formation. 
Comparison of the in vitro lH-HX / lH_ T dR incorporation ratios for the 
CCRF-CEM, CEM-6TGR and T cell hybrid lines confirmed that: 
1) the parental CEM-6TGR cells were HGPRT 
deficient and, 
2) that HAT and phenotype selected hybrids did 
receive functional HGPRT activity following 
fusion with activated T cells. 
This provided strong evidence that true human T cell hybrids were produced. 
4.3.3 Chromosomal analysis 
M-6TGR cells exhibited a modal distribution of chromosome 
number {mean = 92h indicating tetraploidy. Suomalainen et 01 (1980) have 
reported a different observation for the CCRF-CEM line. Their study 
indicated that the CCRF-CEM line consisted of two clones; a near-tetraploid 
clone with a [nodal chromosome number of 85 {70% of cells in line}, and a near-
diploid clone with a modal chromosome number of 44 (30% of cells). The CCRF-
CEM line used in this study does not appear to have the 44 or 85 chromosome 
clone present, and this may simply result from selective enrichment of the 
tetraploid clone in culture or from some form of karyotype evolution. Karyo-
typing of the CCRF-CEM line shortly after its establishment {McCarthy et 01, 
1965}, indicated the presence of an unidentified chromosome "markerll. This 
may correspond to the unidentified chromosome shown in Figure 3.7 (Section 
3.2.3). Two abnormal number nine chromosomes are present in the screen shown. 
The studies by Suomalainen et 01 (1980) of CCRF-CEM (and 5 other ALL 
lines studied) concluded, that during continuous culture the lines have acquired 
profound aberrations in their chromosome sets as well as in their phenotypes 
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(e.g. CCRF-CEM loss of E rosette receptor). The CCRF-CEM line used in this 
study appears to be another example, to add to those described by Suomalainen 
et ai, of lines with both altered chromosomes and altered phenotypes. 
TT -4 cells, 120 days post fusion, had a modal distribution of chromosome 
number with a mean of 92 and showed some evidence of chromosomal 
instability. This could reflect the observations made in the surface phenotype 
studies (Table 3.4). Because of the chromosomal instability evident when the 
karyotyping was performed, cell surface phenotype and HGPRT activity were 
used as the main criteria confirming the success of the hybridisation. 
The development of other techniques confirming hybridisation e.g. isoenzyme 
studies, HLA typing of parental and hybrid cells (Okada et ai, 1981), or short-
term screening assays for constitutive lymphokine secretion were beyond the 
scope of this investigation but may be warranted if somatic cell hybrids are to 
be used as stable sources of human regulatory lymphokines in the future. 
4.3.4 Alternative selective media 
HA T selection is widely used to select for successful somatic cell 
hybrids. Reports (Schachtschabel et ai, 1966; Fox et ai, 1981) have stated that 
the thymidine component of this medium causes growth inhibition of the CEM 
line. An alternative drug selection system using the amido transferase inhibitor 
azaserine combined with hypoxanthine (AH) (Siniscalco et ai, 1969) was utilised 
to select for putative hybrids arising from a fusion experiment. 48 hr ConA-
activated PBLs PEG-fused with the CEM-AGR line were selected in either HAT 
or AH media for 14 days, then conditioned through media lacking anti-metabolites 
(no aminopterin or azaserine respectively) into standard tissue culture medium 
supplemented with 20% FCS. Direct microscopic examination, 30 days post 
fusion, was used to determine the numbers of wells containing viable cells. 9.7% 
of the cells seeded in HAT medium showed evidence of viable cells compared to 
17.4% of wells in AH medium (144 wells of each). This direct comparison suggest-
ed the AH selection system was enabling more hybrids to arise from the fusions 
and this system will be investigated further to determine if this is the case. 
Screening of the hybrid lines using the hybridisation criteria adopted will also be 
performed. 
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4.4 FUNCTIONAL ASSAYS DEVELOPMENT AND VALIDATION 
Assay systems, capable of quantitating human antibody responses in vitro 
to hapten-carrier conjugates were developed. These developmental studies were 
undertaken as part of a continuing project in this laboratory investigating the 
role of a mixed lymphocyte culture-derived suppressor factor (MLC-SF) in 
regulating the activation of cytotoxic T cells (Crosier & Broom, 1981b). It was 
of interest to this group to determine whether the MLC-SF could also regulate 
B cell responses, hence the necessity for a human antibody assay. My role in the 
project was to develop human antibody assays as well as somatic cell hybrids as 
alternative sources of human regulatory lymphokines (especially SFs). The antibody 
assay was therefore used to screen the T cell hybrid lines as well as the studies 
of the MLC-SF; which do not form part of this thesis material. 
One human antibody assay, a mitogen-dependent system, was used to screen 
T cell hybrid-derived supernatants for possible immunoregulatory effects on 
normal human PBL antibody responses. A second assay, a hapten-specific antibody 
system, was also developed. This assay was not used to screen the T cell hybrid 
lines but will be of general use in the future for the investigation of lymphokine 
regulation of antigen or hapten-specific antibody responses. 
4.4.1 Human antibody assay (mitogen-dependent) 
This antibody assay system utilised a RIA to measure total and 
specific antibody production by human PBLs in response to the hapten-carrier 
conjugates DNP-BSA or DNP-KLH in the presence of the polyclonal activator 
PWM (Section 2.6.2). 
As other groups have demonstrated (Volkman et ai, 1981; Clifford-Lane 
et ai, 1981) the polyclonal activator PWM was required to enhance the antigen-
specific antibody response. Culturing PBLs in the absence of antigen or PWM 
failed to produce significant levels of antibody. PBLs cultured with PWM alone 
produced significant levels of anti-hapten antibody (Figs. 3.9, 3.10). 
PW M, in this assay system, was therefore required to trigger hapten-spec if ic 
antibody production as part of the total polyclonal response induced by the 
mitagen. PW M however, has limitations, as it has been shown to "bypass" the 
requirement for histocompatibility in T -B collabaration in specific murine anti-
body responses (Hirano et aI, 1977). Two methods were utilised to circumvent 
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the need for PWM to trigger B cell differentiation and Ig secretion. Hydro-
cortisone (He) was used in an attempt to inhibit Ts cells without affecting Th 
cells {Lobo & Spencer, 1979}, and IL-2 was used to expand the antigen-activated 
Th cells (Acirden et ai, 1979). 
Both He and IL-2 were demonstrated to enhance hapten-specific and total 
IgM antibody responses in the presence of PW M, but antigen plus PW M still 
produced the largest hapten-specific IgM response. This suggested that PWM 
was enhancing the production of a hapten or antigen-specific amplifying factor. 
Figure 3.11 (Section 3.4.1 (a) ) showed that PBLs cultured with DNP-KLH 
and PWM alone produced significantly higher levels of total IgM antibodies 
compared with the other non-PWM-stimulated cultures even though comparable 
levels of hapten-specific antibodies were produced. These observations could 
have two explanations: 
1} the indicator PBLs respond poorly, if at all 
to DNP-KLH (in the absence of PWM}i hence 
the low levels of hapten-specific antibody 
produced. The amplified total IgM response 
(in the presence of DNP-KLH and IL-2 alone) 
could "result from a small number of in vivo-
activated T cells being expanded and stimulated 
in vitro to produce non-specific B cell 
differentiation factors. B cell growth and 
differentiation factors are known to augment 
in vitro B cell responses {Howard et aI, 1982}. 
The minimal response of the indicator PBLs to 
DNP-KLH alone suggest that only low levels of 
antigen-responsive B cells are present in the 
culture. 
2} A second possibility is that factors present in 
the IL-2 containing conditioned-medium, or 
produced by IL-2 responsive T cells, are 
suppressing the anti-hapten response. 
Hapten-specific antibody production was enhanced by PWM but DNP-KLH 
plus PWM gave the largest response (Figure 3.11). He was not observed to 
amplify the response {i.e. by inhibiting Ts cells} suggesting resistance or merely 
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suboptimal levels in the culture. Reduction of the hapten-specific response of 
the indicator PBLs in the presence of IL-2 to less than that of PBL + PW M 
points to active immune suppression or non-specific suppression by factors 
present in the IL-2 medium. 
Studying this culture system has, in addition to aiding the development of 
a simple assay for the quantitation of human antibody responses provided some 
interesting information about human in vitro B cell responses. These include: 
1) specific antibody production is associated with 
polyclonal activation in this system, 
2) antigen-specific B cells can be triggered to 
produce antibody by PWM provided the 
relevant B cells are present in the culture, 
3) at high antigen concentrations antibody 
responses can be suppressed. Eardley et al 
(1976), demonstrated that the adjustment of 
experimental conditions in assay cultures 
significantly affected the regulatory response 
produced by spleen cells educated with SRBC. 
To summarise their study, spleen cells could be 
educated in vitro to induce T help or T suppress-
ion of the antibody response to SRBC. Low doses 
of SRBC induced Th cells whereas high doses 
induced Ts cells in culture. The observations 
made in this human antibody assay may be due 
to analagous effects resulting from the in vitro 
culture conditions adopted. 
4) cell density and vessel geometry are extremely 
important for in vitro B cell responses. 
Clifford-Lane et al (1981) suggested this could 
be explained by the need for enhanced cell-to-
cell contact for the generation of non-specific 
helper factors. ThF have been shown to act by by-
passing the need for linked recognition in immune 
responses (Katz, 1977, p482). 
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Three approaches were used to validate the human antibody RIA. 
1) the IgG and IgM dose response curves described 
in Figure 3.12 are characteristics of ideal bind-
ing in RIAs (Kalmakoff et ai, 1977). 
2) Figure 3.13 showed good inhibition of binding 
occurred when supernatants from a DNP-KLH 
antibody culture were titrated with increasing 
amounts of DNP-BSA and assayed for the levels 
of hapten-specific antibody remaining in solution. 
Titration with ovalbumin had little effect on 
binding whereas with carrier alone (KLH) the 
curve indicates that both carrier and hapten-
specific antibodies were produced in culture 
though hapten-carrier conjugates were more 
effective in inhibiting binding. 
3) the IgG dose response curve shown in Figure 3.14 
indicated that maximum binding of the test IgG 
to the goat anti-human IgG coated plates occurred 
at equivalence (100ng IgG) confirming the 
quantitative nature of the RIA. 
These three methods confirmed that the RIA was measuring specific antibody 
production and furthermore that the culture system could produce antigen or 
hapten-specific antibody in the presence of PWM. 
4.4.2 Human hapten-specific antibody responses (mitogen-independent) . 
A second ant ibody assay, a mitogen-independent hapten-specific 
system, was developed and validated. Even though this system was not used to 
screen the T cell hybrid lines, it has a number of desirable characteristics which 
will enable the assay to be used in the investigation of human B cell responses. 
The optimal culture conditions for the generation of hapten-specific antibody 
were demonstrated to be at a cell density of 1.0 x 10 6 10.2ml, ant igen concentr at-
ion af 1.0)Jg/O.2ml and 5 days with antigen followed by 4 days without antigen. 
The peak of the T cell dependent response was between days 5 and 7 (Section 
3.4.2). 
This assay system overcomes many of the shortcomings of conventional 
human in vitro antibody studies e.g. their reliance on the addition of helper 
factors from activated cells (luzzati et aI, 1976), PWM to provide polyclonal 
activation (Volkman et aI, 1981), allogeneic cells or a high concentration of 
serum supplements to stimulate antibody production (Morimoto et aI, 1981). 
Preimmunisation of the donor with antigen has also been used (Clifford-lane 
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et ai, 1981). As this microculture system circumvents, in particular, the need 
for PW M to stimulate B cell responses to hapten-carrier conjugates, it will aid 
in the investigation of human primary in vitro antibody responses. These studies 
could include PBl responses to regulatory lymphokines, human cell-to-cell 
interactions during immune responses, or the closer investigation of T and B 
cell interactions in disease. 
4.5 FUNCTIONAL STUDIES OF HUMAN T CEll HYBRID LINES 
The human antibody assay (Section 2.6.2) was used to screen supernatants 
derived from the T cell hybrid lines. These experiments aimed to determine· 
whether hybrid supernatants contained regulatory molecules which could in any 
way modify the response of normal indicator PBls to PWM. From the studies 
undertaken in developing the assay it was apparent that significant levels of 
total and hapten-specific antibodies were produced by the indicator PBls in 
response to PWM alone. As the assay was to be used merely to screen hybrid-
derived supernatants for any gross immunoregulatory effects on normal PBl 
antibody responses, PBls st imulated with PWM alone were used as the indicator 
cells. Only total PWM-induced antibody and not hapten-specific antibody levels 
were therefore determined. 
Studies by Grillot-Courvalin et al (1981) and Greene et al (1982), also using 
assay systems measuring PBl responses to PWM, have shown their value in 
screening human T cell hybrids for regulatory effects on human B cell antibody 
responses. 
Hybrid cells were screened for constitutive or inducible (following ConA-
activation) production of factors which could modify the antibody response of 
indicator PBls to PWM. 
4.5.1 Constitutive lymphokine production 
The primary aim of this work was to establish stable sources of 
human immunoregulatory lymphokines, and if possible lymphokines possessing 
suppressive characteristics. Preliminary experiments indicated that hybid-
derived supernatants from all four lines were capable of suppressing, to varying 
extents, a PWM-induced antibody response. Hybrid line TT -4, which exhibited 
the most potent suppressive effect, was used for more detailed studies. 
Supernatants derived from TT -4 hybrid cells were demonstrated to cause a 
dose and producer cell concentrat ion-dependent suppressive effect on the 
generation of an in vitro PWM-induced IgG response (up to 75% for the 3 cell 
concentrations and dilutions tested). Stimulation of the indicator PBLs with PWM 
resulted in a greater than four-fold increase in IgG secretion. This confirmed 
that the assay was working at near optimal mitogenic levels. If this is the case, 
these levels of suppression caused by the hybrid supernatants are therefore 
significant. 
4.5.2 Hybrid induction 
Induction of cultured TT -4 hybrid cells with ConA prior to assaying 
the hybrid-derived supernatants for possible effects on a PWM-induced antibody 
response was undertaken. These experiments aimed to determine if stimulation 
of the hybrids resulted in the enhanced secretion of suppressive, or other 
regulatory lymphokines. 
The results of these studies indicated that ConA pretreatment of the hybrid 
cells (l-10l1g/ml ConA) did not alter to any significant extent the ability of hybrid-
derived supernatants to suppress the IgG response of the PWM-stimulated 
indicator PBLs. 
4.5.3 T cell proliferative responses 
The constitutive ability of the hybrid-derived supernatants to suppress 
a normal B cell antibody response in vitro could be due to a number of possible 
effects. The hybrid activity could be acting on the B cells directly, or alternat-
ively via some other immunoregulatory T cell or antigen presenting cell in the 
indicator culture. The experiments discussed here aimed to investigate if the 
suppression of antibody production was due to a direct effect on T cells in the 
culture. The effect of TT -4 supernatants on the continued proliferation of 
lectin-activated T cells in response to exogenous IL-2 was investigated in an 
attempt to answer this question. 
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Lectin-activation of normal T cells results in their expression of receptors 
for IL-2. Exogenous sources of IL-2 cause the continued proliferation of these 
activated cells. In the absence of IL-2 they fail to proliferate (Gillis et ai, 1978). 
Figure 4.1 describes this phenomenon of IL-2-dependent T cell proHferation. 
FIGURE 4.1 
IL-2-DEPENDENT T CELL PROLIFERATION 
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Mitogen or lectin-activation of normal T cells leads to expression of receptors 
for IL-2. In the presence of exogenous sources of IL-2 activated T cells continue to 
proliferate, whereas in the absence of IL-2 they fail to proliferate. 
TT -4 supernatants were demonstrated to suppress the proliferative response 
of lectin-activated T cells to exogenous IL-2 in a manner dependent on dose and 
concentration of producer cells. In the absence of exogenous sources of IL-2 the 
activated indicator T cells failed to proliferate. TT -4 supernatants enhanced 
their proliferation marginally, but this was not significant when compared to the 
effects of IL-2. This could be due merely to the addition of extra FCS to the 
culture. The ability of TT -4 supernatants to suppress the IL-2-dependent 
proliferation of activated T cells suggests that the activity is in some way inter-
fering with the response to IL-2. The- possible mechanisms of this effect are 
discussed in Sect ion 4.7. 
4.6 BIOCHEMICAL CHARACTERISATION OF HYBRID-DERIVED FACTORS 
The ability of TT -4 supernatants to suppress both B cell antibody and T cell 
proliferative responses suggested that more than one substance present in the 
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supernatant could be causing these effects. Preliminary biochemical character-
isation of the hybrid activity was therefore undertaken. 
Gel filtration of TT -4 supernatants indicated that 3 major fractions; 
corresponding to >250 Kdal (Vo), 120-140 Kdal and 60-80 Kdal respectively, were 
capable of suppressing a T cell proliferative response. This suggested a 60-80 
Kdal suppressive act ivity and possibly an 120-140 Kdal oligomer were present in 
the supernatant. The Vo activity could be due to either high MW oligomers or 
from activity being carried through with the excluded material. Importantly the 
levels of suppression for each MiN range did not merely reflect differences in the 
total protein concentration of the fractions (data not shown). 
No fractions provided significant levels of helper activity for T cell prolif-
eration, perhaps reinforcing the belief that receptor expression by human T cell 
hybrids need not correlate with functional activity (DeFreitas et aI, 1982). 
Further experiments will need to be performed to determine if the different 
M W su ppressive act ivit ies do belong to one or a number of species of molecules. 
Preliminary physicochemical characterisation of TT -4 supernatants indicated 
the suppressive effect on T cell proliferation was acid, alkali and DTT sensitive; 
a me-thyl mannoside, L-fucose and N-acetyl glucosamine affected its activity; but 
interestingly L-rhamnose had only minimal effects on the suppression of T cell 
proliferation. Particular care was taken in treating the control supernatants in 
an identical manner to the test supernatants. This was to exclude the possibility 
that any changes in biological activity of the hybrid supernatants following the 
treatment were due to effects on the FCS supplement, leading to enhancement 
or increased suppression of T cell proliferation. Experiments involving protease 
treatment of control and test supernatants produced inconsistent results in the 
T cell proliferation assay. As the validity of the test data cauld not be assured, 
due to a wide variability in the control responses, these results have not been 
included. 
Several workers have identified human regulatory factors which have similar 
properties and actions to the TT -4 activity described here. Greene et al (1981), 
partially characterised soluble immune suppressor supernatants (SISS) derived from 
ConA-activated normal peripheral blood mononuclear cells. These supernatants 
have been shawn to elaborate 2 suppressor activities; one SISS-T (30-45 Kdal) 
inhibits both mitogen and antigen-induced T cell proliferation and is inactivated 
by N-acetyl glucosamine. The second, SISS-B (60-90 Kdal) inhibits B cell Ig 
production and is inactivated by L-rhamnose. 
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The TT -4 activity may be related to these activities as the stimulation regime 
(lO)lg/ml ConA, 2-5 days) used to activate the normal PBLs could be expected to 
induce the production and secretion of these factors. Greene et al (1982) have also 
described a human suppressor T cell hybrid-derived factor (70-85 Kdal) that 
produced reversible non-cytotoxic inhibition of lectin-activated Ig production. 
Grillot-Courvalin et al (1982) partially characterised a 45 Kdal hybridoma-derived 
factor which suppressed PWM-induced Ig production but not Nocardia-induced 
(T -independent) Ig production. The ability of TT -4 supernatants to inhibit both 
T cell proliferative and B cell antibody responses, differing apparent MWs, 
inactivation by NAG but not by L-rhamnose suggests the activity is related to, 
but still distinct from the previously described factors. 
Important ly it must be determined if the biological effects of TT -4 super-
natants on both T and B cell responses results from a single molecule or a 
number of molecules. The preliminary biochemical studies suggest its biological 
effects cannot be completely explained by the presence of IFN-y in the super-
natants (labile at both pH 2 and 9). Further definitive testing will be necessary 
to confirm these observations. Ethidium bromide - acridine orange staining of 
TT -4 cells confirmed that they were not mycoplasma contaminated suggesting 
the suppressive activity is not mycoplasma-derived. 
4.7 BIOLOGICAL SIGNIFICANCE OF T CELL HYBRID-DERIVED SUPPRESSOR 
FACTOR 
What could be the mechanism and site of action of the suppressor factor (s)? 
The hybridoma TsF of Greene et al (1982) is thought to act directly on B cells or 
monocytes by a non-cytotoxic mechanism rather than indirectly modulating the 
activity of other immunoregulatory T cells. Grillot-Courvalin et al (1982) 
believe their factor is acting direct lyon T cells; again by a non-cytotoxic 
mechanism. 
Studies undertaken in this laboratory by other workers suggest the TT-4 
activity may act by inhibiting T cell proliferation of both T helper/inducer and 
T suppressor/cytotoxic subpopulations, again not via any apparent cytotoxic 
mechanism (Bissell, Macdonald & Crosier, 1983). As the activity also affects 
the T cell-dependent B cell response to PWM, it is tempting to speculate that 
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it may act by interfering with the delivery of or response to the T cell 
proliferation signal of IL-2. Malkovsky et al (1982, 1983) have described a 
murine non-specific suppressor factor (ns II'\IH), which suppressed IL-2 production 
by stimulated lymphocytes. This effect resulted from the non-specific inhibition 
of DNA synthesis. The TT -4 factor may act in an analagous non-specific manner 
or via an IL-2-specific mechanism. The IL-2-specific mechanisms could include; 
binding IL-2 in solution or blocking IL-2 receptor sites, alternatively suppression 
may be mediated within the target cell by blocking the IL-2 signal specifically or 
by non-specific effects on DNA synthesis. It is intended to pursue these possible 
mechanisms by using partially purified IL-2, hybrid suppressor factor{s} and 
cloned IL-2-dependent T cell lines as targets. The possible sites of action of the 
hybrid-derived suppressor activity are summarised in Figure 4.2. 
FIGURE 4.2 
POSSIBLE SITES OF ACTION OF THE TT -4-DERIVED SUPPRESSOR 
FACTOR 
IL-2 
SF 
Several possibilities exist as to how the TT-4-derived Sf could be inhibiting the IL-2-
dependent proliferative response of lectin-activated T cells: 
1. The Sf could bind IL-2 in solution, 
2. Could block. IL-2 receptor sites, 
3. The SF could bind to specific receptors and block the IL-2 signal 
specifically within the target cell or, 
4. Could non-specifically affect DNA synthesis (N). 
4.8 FUTURE STUDIES 
Somatic cell hybridisation techniques have been used to construct T cell 
hybrids betweenm HGPRT deficient human T -ALL line and ConA-activated 
normal human PBLs. One hybrid line, TT -4 was demonstrated to produce 
constitutively an activity which suppressed both B cell antibody and T cell 
proliferative responses. 
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This study has shown that somatic cell hybrids are viable sources for the 
production of human T cell-derived lymphokines. The major shortcoming of the 
technique is the problem of chromosomal instability, presumably leading to the 
loss of phenotypic markers and biological activity. The CCRF-CEM line, while 
permiting the construction of human T cell hybrids is limited by its failure to 
permanently retain parental chromosomes. Recent studies of the TT-4 line have 
indicated that a loss of biological activity has occurred (>6 months in culture). 
This may be as a direct result of the chromosomal instability of the line. 
Repeated early cloning or sterile cell sorting using the FACS may help to over-
come this instability problem and aid in the establishement of hybrids which' 
retain their phenotypic, chromosomal and biological characteristics for longer 
periods. 
A number of biochemical studies need to be performed on the TT -4-derived 
suppressor activity. Are the different MW species identified by gel chromato-
graphy oligomers of one molecule or a number of molecules? Is one activity 
mediating both the T cell and B cell suppressive effects? What is the precise 
mode of action of the suppressive activity? 
In conclusion, future biochemical studies of this and other hybrid-derived 
activities will enable a better understanding of the fundamental role lymphokines 
play in the regulation of human immune responses in both normal and disease 
states. 
l. 
2. 
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APPENDICES 
Amounts of McAbs used to stain human lymphocytes 
Antibodl Supplied Amount/10 6 cells 
Leu-1,2a,3 0.2mg/ml 1)1g 
5, HLA-DR 
Leu-3a + 3b 0.3mg/ml 1.5)1g 
Leu-4 0.2mg/ml 2)1g 
S 2- micro-
globulin 0.6mg/ml 3)1g 
OKT3, T 4, T 6, 1mg/ml 5)1g 
T8, M1 
W6/32 culture 
supernatant 1: 1 0 
HTAl ascites 1: 1 00 
PNA 5mg/ml 0.5mg 
Liquid scintillation counting 
2,5-diphenyloxazole (PPO) 6g/1 
(l,4-bis[2 (4-methyl-5-phenyl-Oxazolyl) ] benzene) (POPOP) 0.01 gil 
in Toluene. 
5mls scintillation fluid added to dried filter discs in counting vials. 
Vials counted in Packard Tri-carb liquid scintillation spectrometer 
Settings CH) window: 50- 1 000 
gain : 50% 
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